Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
J Antimicrob Chemother
    July 2024
  1. JING R, Yi QL, Zhuo C, Kang W, et al
    Establishment of epidemiological cut-off values for eravacycline, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii and Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Jul 16:dkae220. doi: 10.1093.
    >> Share

  2. BAE J, Park JH, Lee M, Jo HJ, et al
    Clinicomicrobiological risk factors for infective endocarditis in viridans group streptococci bacteraemia.
    J Antimicrob Chemother. 2024 Jul 8:dkae231. doi: 10.1093.
    >> Share

  3. SHEEHY J, Scott AP, Henden AS, Kennedy G, et al
    Low rates of complications and beta-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy.
    J Antimicrob Chemother. 2024 Jul 8:dkae209. doi: 10.1093.
    >> Share

  4. SHAH S, Clarke LG, Ludwig J, Burgdorf S, et al
    Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2024 Jul 1:dkae198. doi: 10.1093.
    >> Share

  5. HERMANN L, Schoning V, Drager S, Rentsch K, et al
    Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection.
    J Antimicrob Chemother. 2024 Jul 1:dkae207. doi: 10.1093.
    >> Share

  6. VALDEZATE S, Medina-Pascual MJ, Villalon P, Garrido N, et al
    Co-occurrence of the cephalosporinase cepA and carbapenemase cfiA genes in a Bacteroides fragilis division II strain, an unexpected finding.
    J Antimicrob Chemother. 2024;79:1683-1687.
    >> Share

  7. ZHANG LC, Li QY, Zhang YQ, Shan TC, et al
    Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation.
    J Antimicrob Chemother. 2024;79:1697-1705.
    >> Share

  8. DAABOUL D, Osman M, Kassem II, Yassine I, et al
    Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
    J Antimicrob Chemother. 2024;79:1614-1618.
    >> Share

  9. CHARFI R, Tazi A, Sereme Y, Plainvert C, et al
    High-level expression of chromosomally encoded SHV-1 beta-lactamase reduces the susceptibility to cefiderocol of clinical isolates of Klebsiella pneumoniae.
    J Antimicrob Chemother. 2024;79:1711-1714.
    >> Share

  10. CANCELA COSTA A, Kritikos A, Glampedakis E, Da Silva Pereira Clara J, et al
    Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
    J Antimicrob Chemother. 2024;79:1668-1672.
    >> Share

  11. IVANOVA M, Ovsepian A, Leekitcharoenphon P, Seyfarth AM, et al
    Azithromycin resistance in Escherichia coli and Salmonella from food-producing animals and meat in Europe.
    J Antimicrob Chemother. 2024;79:1657-1667.
    >> Share

  12. BIGHI N, Freitas F, Morgado S, Cipriano R, et al
    Deciphering the accessory genome of a novel Klebsiella pneumoniae lineage in the Brazilian Amazon region and its potential contribution to the emergence of a high-risk clone.
    J Antimicrob Chemother. 2024;79:1709-1711.
    >> Share

  13. CHEN PJ, Tan MC, Huang WC, Hsu SY, et al
    The individual contributions of blaB, blaGOB and blaCME on MICs of beta-lactams in Elizabethkingia anophelis.
    J Antimicrob Chemother. 2024;79:1577-1580.
    >> Share

  14. SUBBARAO S, Boyd SE, Basarab M, Riley P, et al
    Comment on: In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019).
    J Antimicrob Chemother. 2024;79:1715-1716.
    >> Share

  15. TAYSI MR, Ocal D, Cicek Senturk G, Caliskan E, et al
    Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) for carbapenemase/ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates, and its effect on mortality.
    J Antimicrob Chemother. 2024;79:1540-1546.
    >> Share

  16. WEERDENBURG H, Walker H, Curtis N, Duffull S, et al
    Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration.
    J Antimicrob Chemother. 2024;79:1493-1507.
    >> Share

    June 2024
  17. CHEN PY, Huang YS, Chuang YC, Wang JT, et al
    Implication of genotypes for prognosis of Candida glabrata bloodstream infections.
    J Antimicrob Chemother. 2024 Jun 22:dkae200. doi: 10.1093.
    >> Share

  18. CHANCHAITHONG P, Chueahiran S, Pinpimai K, Sroithongkham P, et al
    Chromosomal and plasmid localization of ileS2 in high-level mupirocin-resistant Staphylococcus pseudintermedius and Staphylococcus aureus isolated from canine and feline origins.
    J Antimicrob Chemother. 2024 Jun 12:dkae172. doi: 10.1093.
    >> Share

  19. ALTARAWNEH H, Alhomra T, Alharbi M, Fan Y, et al
    Synergistic bactericidal activity of a novel dual beta-lactam combination against methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Jun 4:dkae165. doi: 10.1093.
    >> Share

  20. RAHMAT ULLAH S, Jamal M, Rahman A, Andleeb S, et al
    Comprehensive insights into Klebsiella pneumoniae: unravelling clinical impact, epidemiological trends and antibiotic-resistance challenges.
    J Antimicrob Chemother. 2024 Jun 4:dkae184. doi: 10.1093.
    >> Share

  21. ELKAYAL O, Mertens B, Wauters J, Debaveye Y, et al
    Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study.
    J Antimicrob Chemother. 2024 Jun 3:dkae160. doi: 10.1093.
    >> Share

  22. MOURAD A, Smith AG, Troy JD, Holland TL, et al
    Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.
    J Antimicrob Chemother. 2024;79:1456-1461.
    >> Share

  23. GAUTHIER A, Tlili L, Battu S, Le Moan C, et al
    Sedimentation field-flow fractionation for rapid phenotypic antimicrobial susceptibility testing: a pilot study.
    J Antimicrob Chemother. 2024;79:1450-1455.
    >> Share

  24. MARURI-ARANSOLO A, Lopez-Causape C, Hernandez-Garcia M, Garcia-Castillo M, et al
    In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain.
    J Antimicrob Chemother. 2024;79:1432-1440.
    >> Share

  25. DURICEK M, Halmova K, Krutova M, Sykorova B, et al
    Is shorter also better in the treatment of Clostridioides difficile infection?
    J Antimicrob Chemother. 2024;79:1413-1417.
    >> Share

  26. BIENVENU AL, Cour M, Pavese P, Guichon C, et al
    Correlation between antifungal clinical practices and a new clinical decision support system ANTIFON-CLIC(R) for the treatment of invasive candidiasis: a retrospective multicentre study.
    J Antimicrob Chemother. 2024;79:1407-1412.
    >> Share

  27. LIU M, Wang M, Huang M, Gao Q, et al
    Iron efflux by IetA enhances beta-lactam aztreonam resistance and is linked to oxidative stress through cellular respiration in Riemerella anatipestifer.
    J Antimicrob Chemother. 2024;79:1385-1396.
    >> Share

  28. LEWIS R, Niazi-Ali S, McIvor A, Kanj SS, et al
    Triazole antifungal drug interactions-practical considerations for excellent prescribing.
    J Antimicrob Chemother. 2024;79:1203-1217.
    >> Share

  29. NAVICKAITE I, Holmes H, Dondi L, Randall L, et al
    Occurrence and characterization of rmtB-harbouring Salmonella and Escherichia coli isolates from a pig farm in the UK.
    J Antimicrob Chemother. 2024;79:1329-1336.
    >> Share

  30. KOLTE B, Nubel U
    Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
    J Antimicrob Chemother. 2024;79:1320-1328.
    >> Share

  31. KARAKITSIOS E, Dokoumetzidis A
    Extrapolation of lung pharmacokinetics of antitubercular drugs from preclinical species to humans using PBPK modelling.
    J Antimicrob Chemother. 2024;79:1362-1371.
    >> Share

  32. WANGCHINDA W, Pogue JM, Thamlikitkul V, Leelawattanachai P, et al
    Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2024;79:1372-1379.
    >> Share

  33. NISSIM Y, LaSala PR, Slain D
    A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales.
    J Antimicrob Chemother. 2024;79:1463-1466.
    >> Share

    May 2024
  34. LEE YL, Wang WY, Ko WC, Hsueh PR, et al
    Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018-2021.
    J Antimicrob Chemother. 2024 May 17:dkae140. doi: 10.1093.
    >> Share

  35. MILLS RO, Dadzie I, Le-Viet T, Baker DJ, et al
    Genomic diversity and antimicrobial resistance in clinical Klebsiella pneumoniae isolates from tertiary hospitals in Southern Ghana.
    J Antimicrob Chemother. 2024 May 16:dkae123. doi: 10.1093.
    >> Share

  36. MENENDEZ ALVARADO LR, Margulis Landayan A, Williams KN, Frederick CM, et al
    Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections.
    J Antimicrob Chemother. 2024 May 8:dkae135. doi: 10.1093.
    >> Share

  37. FOUAD A, Nicolau SE, Tamma PD, Simner PJ, et al
    Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
    J Antimicrob Chemother. 2024;79:1176-1181.
    >> Share

  38. ZHENG M, Li FH, Liu J, Li WJ, et al
    Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2024;79:1069-1080.
    >> Share

  39. GALANI I, Souli M, Katsala D, Karaiskos I, et al
    In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
    J Antimicrob Chemother. 2024;79:1101-1108.
    >> Share

  40. MALLART E, Guerin F, Amoura A, Le Scouarnec M, et al
    Impact of the phenotypic expression of temocillin resistance in Escherichia coli on temocillin efficacy in a murine peritonitis model.
    J Antimicrob Chemother. 2024;79:1051-1059.
    >> Share

  41. UNEMO M, Golparian D, Oxelbark J, Kong FYS, et al
    Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea.
    J Antimicrob Chemother. 2024;79:1006-1013.
    >> Share

  42. BERGER A, Badell E, Ahman J, Matuschek E, et al
    Corynebacterium diphtheriae and Corynebacterium ulcerans: development of EUCAST methods and generation of data on which to determine breakpoints.
    J Antimicrob Chemother. 2024;79:968-976.
    >> Share

  43. URBANOWICZ P, Izdebski R, Biedrzycka M, Gniadkowski M, et al
    VIM-type metallo-beta-lactamase (MBL)-encoding genomic islands in Pseudomonas spp. in Poland: predominance of clc-like integrative and conjugative elements (ICEs).
    J Antimicrob Chemother. 2024;79:1030-1037.
    >> Share

  44. MAESTRO DE LA CALLE G, Velez J, Mateo Flores J, Garcia Barrio N, et al
    Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs).
    J Antimicrob Chemother. 2024;79:1019-1022.
    >> Share

  45. SPERNOVASILIS N, Tsioutis C
    Not surprising: a rebound in antibacterial consumption in Europe, with Cyprus and Greece on the podium.
    J Antimicrob Chemother. 2024;79:933-934.
    >> Share

  46. DUQUE M, Bonnin RA, Dortet L
    Comparison of the French novel disc diffusion-based algorithm and the current EUCAST guidelines for the screening of carbapenemase-producing Enterobacterales.
    J Antimicrob Chemother. 2024;79:1194-1196.
    >> Share

    April 2024
  47. PHAISAL W, Albitar O, Chariyavilaskul P, Jantarabenjakul W, et al
    Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection.
    J Antimicrob Chemother. 2024 Apr 25:dkae059. doi: 10.1093.
    >> Share

  48. STEMKENS R, Mouhdad C, Franssen EJF, Touw D, et al
    Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations.
    J Antimicrob Chemother. 2024 Apr 6:dkae105. doi: 10.1093.
    >> Share

  49. WANGCHINDA W, Kaye KS, Patel TS, Albin OR, et al
    A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended beta-lactam-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2024 Apr 6:dkae104. doi: 10.1093.
    >> Share

  50. MACFADYEN AC, Paterson GK
    Methicillin resistance in Staphylococcus pseudintermedius encoded within novel staphylococcal cassette chromosome mec (SCCmec) variants.
    J Antimicrob Chemother. 2024 Apr 2:dkae096. doi: 10.1093.
    >> Share

  51. VAN INGEN J
    Why do we use 100 mg of clofazimine in TB and NTM treatment?
    J Antimicrob Chemother. 2024;79:697-702.
    >> Share

  52. RODRIGUEZ-OCHOA JL, Perez-Palacios P, Merino-Bohorquez V, Ortiz-Padilla M, et al
    Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model.
    J Antimicrob Chemother. 2024;79:784-789.
    >> Share

  53. REYES BARROS T, Gutierrez Torres W, Garcia Canete P, Cerda Lorca J, et al
    Effect of different strategies for excluding duplicate cultures on the correlation between hospital resistance rates and antibiotic consumption.
    J Antimicrob Chemother. 2024;79:774-778.
    >> Share

  54. BOULEKBACHE A, Maldonado F, Kavafian R, Ferry T, et al
    Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2024;79:712-721.
    >> Share

  55. DAABOUL D, Kassem II, Yassine I, Hamze M, et al
    Emergence of NDM-1, VIM-4 and CTX-M-15-co-harbouring Enterobacter xiangfangensis in a bloodstream infection.
    J Antimicrob Chemother. 2024;79:923-925.
    >> Share

  56. LAI T, Yeo CY, Rockliff B, Stokes M, et al
    Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review.
    J Antimicrob Chemother. 2024;79:703-711.
    >> Share

    March 2024
  57. HARMER CJ, Cahill SM, Kenyon JJ, Hall RM, et al
    Aminoglycoside resistance genes in early members of the Acinetobacter baumannii ST78A (SMAL, Italian clone) reside in an IS26-bounded island in the chromosome.
    J Antimicrob Chemother. 2024 Mar 26:dkae064. doi: 10.1093.
    >> Share

  58. GOLPARIAN D, Bazzo ML, Ahlstrand J, Schorner MA, et al
    Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
    J Antimicrob Chemother. 2024 Mar 22:dkae075. doi: 10.1093.
    >> Share

  59. PITT-KENDALL R, Sun S, Hughes S, Merrick R, et al
    Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016-20.
    J Antimicrob Chemother. 2024 Mar 22:dkae073. doi: 10.1093.
    >> Share

  60. TESSIER E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, et al
    Comparison of the in vitro activities of delafloxacin and comparators against Staphylococcus epidermidis clinical strains involved in osteoarticular infections: a CRIOGO multicentre retrospective study.
    J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
    >> Share

  61. PHILIP A, Oueslati S, Villa F, Pannetier C, et al
    Development of an ultrafast PCR to detect clinically relevant acquired vancomycin-resistance genes from cultured enterococci.
    J Antimicrob Chemother. 2024 Mar 19:dkae062. doi: 10.1093.
    >> Share

  62. KITTL S, Brodard I, Tresch M, Perreten V, et al
    Novel tetracycline resistance gene tet(65) located on a multi-resistance Corynebacterium plasmid.
    J Antimicrob Chemother. 2024 Mar 18:dkae066. doi: 10.1093.
    >> Share

  63. YUNIVITA V, Gafar F, Santoso P, Chaidir L, et al
    Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia.
    J Antimicrob Chemother. 2024 Mar 9:dkae057. doi: 10.1093.
    >> Share

  64. ANJUM MF, Duggett N, Sheldon E, Sharma M, et al
    Genomics to detect transmission of livestock-associated methicillin-resistant Staphylococcus aureus from UK pigs in abattoirs during slaughter.
    J Antimicrob Chemother. 2024 Mar 5:dkae052. doi: 10.1093.
    >> Share

  65. CHEN RZ, Lu PL, Yang TY, Lin SY, et al
    Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes.
    J Antimicrob Chemother. 2024;79:648-655.
    >> Share

  66. MOREELS N, Boven A, Gressani O, Andersson FL, et al
    The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence.
    J Antimicrob Chemother. 2024;79:608-616.
    >> Share

  67. SELBY PR, Heffernan AJ, Yeung D, Warner MS, et al
    Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients.
    J Antimicrob Chemother. 2024;79:567-577.
    >> Share

    February 2024
  68. VAN HAL SJ, Jensen SO, Tong SYC, Bentley S, et al
    Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2024 Feb 27:dkae048. doi: 10.1093.
    >> Share

  69. FANG ZY, Zhang ZY, Zheng YD, Lei D, et al
    Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR.
    J Antimicrob Chemother. 2024 Feb 27:dkae051. doi: 10.1093.
    >> Share

  70. BAYART J, Drouet J, Peycelon M, Mariani P, et al
    Temocillin for febrile urinary tract infections caused by ESBL-producing Enterobacteriaceae in children: a monocentric exposed/non-exposed study.
    J Antimicrob Chemother. 2024 Feb 27:dkae053. doi: 10.1093.
    >> Share

  71. COTRONEO N, Stokes SS, Pucci MJ, Rubio A, et al
    Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection.
    J Antimicrob Chemother. 2024 Feb 23:dkae046. doi: 10.1093.
    >> Share

  72. JACQUELINE C, Samper-Cativiela C, Monzon Fernandez S, Ugarte-Ruiz M, et al
    Phenotypic and genetic characterization of antimicrobial resistance in Salmonella enterica serovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021.
    J Antimicrob Chemother. 2024 Feb 16:dkae029. doi: 10.1093.
    >> Share

  73. BRENCIANI A, Cinthi M, Coccitto SN, Massacci FR, et al
    Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal lineage carrying optrA.
    J Antimicrob Chemother. 2024 Feb 15:dkae039. doi: 10.1093.
    >> Share

  74. WESTBROOK KJ, Chilambi GS, Stellfox ME, Nordstrom HR, et al
    Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
    J Antimicrob Chemother. 2024 Feb 9:dkae032. doi: 10.1093.
    >> Share

  75. ATAMNA A, Yeshurun M, Shargian L, Raanani P, et al
    Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations.
    J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.
    >> Share

  76. HELBO T, Boel JB, Bartels MD, Ahlstrom MG, et al
    Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment.
    J Antimicrob Chemother. 2024 Feb 9:dkae036. doi: 10.1093.
    >> Share

  77. SOMAJO S, Nilsson F, Ekelund O, Unemo M, et al
    Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry-proof of concept for seven clinically relevant antimicrobials.
    J Antimicrob Chemother. 2024 Feb 9:dkae034. doi: 10.1093.
    >> Share

  78. ROY S, Morita D, Bhattacharya S, Dutta S, et al
    Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India.
    J Antimicrob Chemother. 2024 Feb 9:dkae024. doi: 10.1093.
    >> Share

  79. MCHUGH MP, Pettigrew KA, Taori S, Evans TJ, et al
    Consideration of within-patient diversity highlights transmission pathways and antimicrobial resistance gene variability in vancomycin-resistant Enterococcus faecium.
    J Antimicrob Chemother. 2024 Feb 7:dkae023. doi: 10.1093.
    >> Share

  80. LAITILA T, Sankilampi U, Renko M, Kokki M, et al
    Comment on: Identifying a therapeutic target for vancomycin against staphylococci in young infants.
    J Antimicrob Chemother. 2024 Feb 2:dkae014. doi: 10.1093.
    >> Share

  81. VAN OS W, Zeitlinger M
    Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections.
    J Antimicrob Chemother. 2024;79:443-446.
    >> Share

  82. RANDO E, Salvati F, Sangiorgi F, Catania F, et al
    Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort s
    J Antimicrob Chemother. 2024;79:453-461.
    >> Share

  83. BLOOMFIELD M, van der Werff K, Todd S, Balm M, et al
    Effect of directive laboratory comments on prescribing response to positive throat swab cultures.
    J Antimicrob Chemother. 2024;79:334-338.
    >> Share

  84. KON H, Lurie-Weinberger MN, Lugassy C, Chen D, et al
    Use of Fourier-transform infrared spectroscopy for real-time outbreak investigation of OXA-48-producing Escherichia coli.
    J Antimicrob Chemother. 2024;79:349-353.
    >> Share

  85. HOSAKA Y, Muraki Y, Kajihara T, Kawakami S, et al
    Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
    J Antimicrob Chemother. 2024;79:312-319.
    >> Share

  86. MATSUO T, Wurster S, Jiang Y, Sasaki K, et al
    Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.
    J Antimicrob Chemother. 2024;79:297-306.
    >> Share

    January 2024
  87. SACRAMENTO AG, Sartori L, Fontana H, Fuga B, et al
    Healthcare-associated vanA-positive Enterococcus faecium clone ST612 emerging as pathogen of companion animals in Brazil.
    J Antimicrob Chemother. 2024 Jan 25:dkae010. doi: 10.1093.
    >> Share

  88. MAZZITELLI M, Scaglione V, Cattarin L, Franchin E, et al
    Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses.
    J Antimicrob Chemother. 2024 Jan 16:dkad410. doi: 10.1093.
    >> Share

  89. FLEITAS O, Fontes W, De Souza CM, Da Costa MC, et al
    A proteomic perspective on the resistance response of Klebsiella pneumoniae to antimicrobial peptide PaDBS1R1.
    J Antimicrob Chemother. 2024;79:112-122.
    >> Share

  90. RITCHIE G, Chorlton SD, Matic N, Bilawka J, et al
    WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing.
    J Antimicrob Chemother. 2024;79:55-60.
    >> Share

  91. SINGH S, Boorgula GD, Aryal S, Philley JV, et al
    Sarecycline pharmacokinetics/pharmacodynamics in the hollow-fibre model of Mycobacterium avium complex: so near and yet so far.
    J Antimicrob Chemother. 2024;79:96-99.
    >> Share

  92. TAN MC, Huang YC, Chen PJ, Huang WC, et al
    In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species.
    J Antimicrob Chemother. 2024;79:200-202.
    >> Share

    December 2023
  93. MASSACCI FR, Cucco L, Paniccia M, Luppi A, et al
    Streptococcus suis serotype 9 in Italy: genomic insights into high-risk clones with emerging resistance to penicillin.
    J Antimicrob Chemother. 2023 Dec 28:dkad395. doi: 10.1093.
    >> Share

  94. XU C, Li Y, Li Y, Huang L, et al
    Characterization of an ST38 carbapenem-resistant and highly virulent Escherichia coli carrying conjugatively transferable ColV virulence-resistance and blaNDM-5-positive resistance plasmids.
    J Antimicrob Chemother. 2023 Dec 28:dkad403. doi: 10.1093.
    >> Share

  95. OMAR S, Whitfield MG, Nolan MB, Ngom JT, et al
    Bedaquiline for treatment of non-tuberculous mycobacteria (NTM): a systematic review and meta-analysis.
    J Antimicrob Chemother. 2023 Dec 22:dkad372. doi: 10.1093.
    >> Share

  96. MANTZOURANI E, Ahmed H, Evans A, Gunnarsson R, et al
    A pharmacy-led sore throat test and treat (STTT) service: antigen testing and antibiotic supply rates during the period of heightened public awareness of Group A Streptococcus infections.
    J Antimicrob Chemother. 2023 Dec 22:dkad388. doi: 10.1093.
    >> Share

  97. ZHAO M, He S, Wen R, Li C, et al
    Membrane vesicles derived from Enterococcus faecalis promote the co-transfer of important antibiotic resistance genes located on both plasmids and chromosomes.
    J Antimicrob Chemother. 2023 Dec 18:dkad381. doi: 10.1093.
    >> Share

  98. COMBRINCK J, Tshavhungwe P, Rohlwink U, Enslin N, et al
    Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis.
    J Antimicrob Chemother. 2023 Dec 15:dkad371. doi: 10.1093.
    >> Share

  99. ERTL NG, Anderson TK, Pardo CJ, Maidment TI, et al
    Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia.
    J Antimicrob Chemother. 2023 Dec 15:dkad373. doi: 10.1093.
    >> Share

  100. BUIS DTP, van der Vaart TW, Prins JM, van der Meer JTM, et al
    Correction to: Comparative effectiveness of beta-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
    J Antimicrob Chemother. 2023 Dec 11:dkad385. doi: 10.1093.
    >> Share

  101. DONA V, Nordmann P, Kittl S, Schuller S, et al
    Emergence of OXA-48-producing Enterobacter hormaechei in a Swiss companion animal clinic and their genetic relationship to clinical human isolates.
    J Antimicrob Chemother. 2023;78:2950-2960.
    >> Share

  102. SHENG Q, Wang N, Zhou Y, Deng X, et al
    A new function of thymol nanoemulsion for reversing colistin resistance in Salmonella enterica serovar Typhimurium infection.
    J Antimicrob Chemother. 2023;78:2983-2994.
    >> Share

  103. WANG X, Qin J, Xiang G, Wang C, et al
    Nosocomial dissemination of blaIMP-4 among Klebsiella pneumoniae by horizontal gene transfer and clonal spread: the epidemic IncN plasmids and the emerging high-risk IMP-4-producing ST101 clone.
    J Antimicrob Chemother. 2023;78:2890-2894.
    >> Share

  104. HERVOCHON C, Hennart B, Leroy AG, Corvec S, et al
    Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
    J Antimicrob Chemother. 2023;78:2919-2925.
    >> Share

  105. HAMON A, Benaboud S, Anjou M, Thoreau B, et al
    Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis?
    J Antimicrob Chemother. 2023;78:3005-3006.
    >> Share

  106. CORCIONE S, Vita D, De Nicolo A, Scabini S, et al
    Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient.
    J Antimicrob Chemother. 2023;78:3003-3004.
    >> Share

    November 2023
  107. JIANG N, Chen H, Cheng L, Fu Q, et al
    Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China.
    J Antimicrob Chemother. 2023 Nov 29:dkad365. doi: 10.1093.
    >> Share

  108. BEREDAKI MI, Pournaras S, Meletiadis J
    A new PK/PD target for assessing efficacy of micafungin against Candida parapsilosis.
    J Antimicrob Chemother. 2023 Nov 24:dkad360. doi: 10.1093.
    >> Share

  109. LEFRANC M, Accoceberry I, Fitton-Ouhabi V, Biteau N, et al
    Rapamycin and caspofungin show synergistic antifungal effects in caspofungin-susceptible and caspofungin-resistant Candida strains in vitro.
    J Antimicrob Chemother. 2023 Nov 22:dkad359. doi: 10.1093.
    >> Share

  110. NING YT, Sun TS, Dai RC, Luo ZY, et al
    Emergence of multiple fluconazole-resistant Candida parapsilosis sensu stricto clones with persistence and transmission in China.
    J Antimicrob Chemother. 2023 Nov 22:dkad356. doi: 10.1093.
    >> Share

  111. DAI X, Sun J, Zhao W, Wang J, et al
    Emergence of a novel ISS1N-optrA-carrying transposon within an integrative and conjugative element from Streptococcus parasuis.
    J Antimicrob Chemother. 2023 Nov 15:dkad347. doi: 10.1093.
    >> Share

  112. BOGLIONE-KERRIEN C, Zerrouki S, Le Bot A, Camus C, et al
    Can we predict the influence of inflammation on voriconazole exposure? An overview.
    J Antimicrob Chemother. 2023;78:2630-2636.
    >> Share

  113. KANESAKA I, Ohno A, Morita M, Katsuse AK, et al
    Epigenetic effects of ceftriaxone-resistant Neisseria gonorrhoeae FC428 mosaic-like sequences found in PenA sequences unique to Neisseria subflava and related species.
    J Antimicrob Chemother. 2023;78:2683-2690.
    >> Share

  114. WANG J, Jiang Y, Tian YQ, Qin YY, et al
    Detection of cfr in Klebsiella pneumoniae from pig feed in China.
    J Antimicrob Chemother. 2023;78:2774-2776.
    >> Share

    October 2023
  115. DUBERT M, Kably B, Derobertmasure A, Podglajen I, et al
    Evaluating the heart valve tissue diffusion of amoxicillin in infective endocarditis: a pilot prospective observational non-comparative study.
    J Antimicrob Chemother. 2023 Oct 25:dkad330. doi: 10.1093.
    >> Share

  116. CALADO NOGUEIRA DE MOURA V, Nguyen MH, Hunkins JJ, Daley CL, et al
    In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022.
    J Antimicrob Chemother. 2023 Oct 21:dkad317. doi: 10.1093.
    >> Share

  117. TRUSWELL A, Lee ZZ, Stegger M, Blinco J, et al
    Augmented surveillance of antimicrobial resistance with high-throughput robotics detects transnational flow of fluoroquinolone-resistant Escherichia coli strain into poultry.
    J Antimicrob Chemother. 2023 Oct 21:dkad323. doi: 10.1093.
    >> Share

  118. CINTHI M, Coccitto SN, Simoni S, Zeni G, et al
    Characterization of a non-functional erm(T) gene in a clinical Enterococcus faecium strain.
    J Antimicrob Chemother. 2023 Oct 14:dkad321. doi: 10.1093.
    >> Share

  119. BOCK M, Van Hasselt JGC, Schwartz F, Wang H, et al
    Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
    J Antimicrob Chemother. 2023 Oct 12:dkad316. doi: 10.1093.
    >> Share

  120. HALLIDAY C, Kim HY, Tay E, Chen SCA, et al
    Exploring synergy between azole antifungal drugs and statins for Candida auris.
    J Antimicrob Chemother. 2023 Oct 12:dkad303. doi: 10.1093.
    >> Share

  121. SIOPI M, Georgiou PC, Pournaras S, Meletiadis J, et al
    Optimization of the EUCAST reference broth microdilution method for echinocandin susceptibility testing of Aspergillus fumigatus.
    J Antimicrob Chemother. 2023 Oct 9:dkad306. doi: 10.1093.
    >> Share

  122. PICCICA M, Spinicci M, Botta A, Bianco V, et al
    Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
    J Antimicrob Chemother. 2023 Oct 9:dkad298. doi: 10.1093.
    >> Share

  123. TRAN A, Zureik M, Sibiude J, Drouin J, et al
    Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010-19 period.
    J Antimicrob Chemother. 2023;78:2535-2543.
    >> Share

  124. GIACOBBE DR, Marelli C, Cattardico G, Fanelli C, et al
    Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
    J Antimicrob Chemother. 2023;78:2505-2514.
    >> Share

  125. PAPPAS PG, Vazquez JA, Oren I, Rahav G, et al
    Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial.
    J Antimicrob Chemother. 2023;78:2471-2480.
    >> Share

  126. WANG J, Zhang XX, Jiang Y, Mei CY, et al
    Detection of blaNDM-1 in Moellerella wisconsensis from mutton, China.
    J Antimicrob Chemother. 2023;78:2599-2601.
    >> Share

    September 2023
  127. MOK S, Roycroft E, Flanagan PR, Wagener J, et al
    Investigation of genomic mutations and their association with phenotypic resistance to new and repurposed drugs in Mycobacterium tuberculosis complex clinical isolates.
    J Antimicrob Chemother. 2023 Sep 23:dkad252. doi: 10.1093.
    >> Share

  128. AKERLUND A, Serrander L, Sundqvist M
    Short incubation of disc diffusion for Streptococcus pneumoniae and Haemophilus influenzae to reduce time to susceptibility report.
    J Antimicrob Chemother. 2023 Sep 5:dkad272. doi: 10.1093.
    >> Share

  129. ZHOU W, Jin Y, Shen P, Chen W, et al
    Novel SCCmec variants in clonal complex 398 and lineage-specific pseudo-SCCmec identified in ST88 MRSA from invasive bloodstream infections in China.
    J Antimicrob Chemother. 2023;78:2366-2375.
    >> Share

  130. BECERRA-APARICIO F, Gomez-Zorrilla S, Hernandez-Garcia M, Gijon D, et al
    Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
    J Antimicrob Chemother. 2023;78:2291-2296.
    >> Share

  131. ROHDE AM, Mischnik A, Behnke M, Dinkelacker A, et al
    Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019.
    J Antimicrob Chemother. 2023;78:2274-2282.
    >> Share

  132. ATTWOOD M, Griffin P, Noel AR, Albur M, et al
    Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic mod
    J Antimicrob Chemother. 2023;78:2254-2262.
    >> Share

  133. FRESAN D, Luque S, Sorli L, Grau S, et al
    Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections-authors' response.
    J Antimicrob Chemother. 2023;78:2385-2386.
    >> Share

  134. VAN HAL SJ, Whiley DM, Le T, Ray S, et al
    Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.
    J Antimicrob Chemother. 2023;78:2203-2208.
    >> Share

  135. BAVARO DF, Belati A, Diella L, Frallonardo L, et al
    Loading dose plus continuous/extended infusion versus intermittent bolus of beta-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study.
    J Antimicrob Chemother. 2023;78:2175-2184.
    >> Share

  136. TISEO G, Suardi LR, Leonildi A, Giordano C, et al
    Meropenem/vaborbactam plus aztreonam for the treatment of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae infections.
    J Antimicrob Chemother. 2023;78:2377-2379.
    >> Share

    August 2023
  137. POWELL LM, Choi SJ, Haught BL, Demkowicz R, et al
    Prevalence of erythromycin-resistant emm92-type invasive group A streptococcal infections among injection drug users in West Virginia, United States, 2021-23.
    J Antimicrob Chemother. 2023 Aug 28:dkad268. doi: 10.1093.
    >> Share

  138. MOK HT, Teng CB, Bergin S, Hon PY, et al
    Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (PSSA) bacteraemia.
    J Antimicrob Chemother. 2023 Aug 19:dkad263. doi: 10.1093.
    >> Share

  139. GALARION LH, Trigwell J, Mohamad M, Nakamoto JA, et al
    The native ABC-F proteins of Staphylococcus aureus do not contribute to intrinsic resistance against ribosome-targeting antibacterial drugs.
    J Antimicrob Chemother. 2023 Aug 16:dkad238. doi: 10.1093.
    >> Share

  140. DOTEL R, Gilbert GL, Hutabarat SN, Davis JS, et al
    Effectiveness of adjunctive rifampicin for treatment of Staphylococcus aureus bacteraemia: a systematic review and meta-analysis of randomized controlled trials.
    J Antimicrob Chemother. 2023 Aug 16:dkad214. doi: 10.1093.
    >> Share

  141. GREIG DR, Do Nascimento V, Olonade I, Swift C, et al
    Surveillance of antimicrobial resistant Shiga toxin-producing E. coli O157:H7 in England, 2016-2020.
    J Antimicrob Chemother. 2023 Aug 7:dkad231. doi: 10.1093.
    >> Share

  142. SKJOT-ARKIL H, Rune Nanthan K, Chen M, Rosenvinge FS, et al
    Carrier prevalence of Clostridioides difficile in emergency departments and the association of prior antibiotic consumption: a combined cross-sectional and nested case-control study.
    J Antimicrob Chemother. 2023;78:2089-2096.
    >> Share

  143. CARTER C, Hutchison A, Rudder S, Trotter E, et al
    Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK.
    J Antimicrob Chemother. 2023;78:2028-2036.
    >> Share

  144. GAY N, Rabenandrasana MAN, Panandiniaina HP, Rakotoninidrina MF, et al
    One Health compartment analysis of ESBL-producing Escherichia coli reveals multiple transmission events in a rural area of Madagascar.
    J Antimicrob Chemother. 2023;78:1848-1858.
    >> Share

  145. DE LA VILLA S, Sanchez-Carrillo C, Sanchez-Martinez C, Cercenado E, et al
    Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY).
    J Antimicrob Chemother. 2023;78:1948-1954.
    >> Share

  146. STEMLER J, Mellinghoff SC, Khodamoradi Y, Sprute R, et al
    Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    J Antimicrob Chemother. 2023;78:1813-1826.
    >> Share

  147. SAATHOFF M, Tedin K, Gratz S, Schwerk P, et al
    Albicidin independency of multidrug efflux systems in Salmonella enterica serovar Typhimurium.
    J Antimicrob Chemother. 2023;78:2102-2104.
    >> Share

  148. HERSHKO Y, Levytskyi K, Rannon E, Assous MV, et al
    Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
    J Antimicrob Chemother. 2023 Aug 1:dkad236. doi: 10.1093.
    >> Share

    July 2023
  149. ALAM F, Blackburn SA, Davis J, Massar K, et al
    Pseudomonas aeruginosa increases the susceptibility of Candida albicans to amphotericin B in dual-species biofilms.
    J Antimicrob Chemother. 2023 Jul 31:dkad228. doi: 10.1093.
    >> Share

  150. BENDER JK, Baufeld E, Becker K, Claus H, et al
    CHROMAgar LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients-a multicentre study approach, 2021-2022.
    J Antimicrob Chemother. 2023 Jul 20:dkad218. doi: 10.1093.
    >> Share

  151. ASLAN AT, Tabah A, Koylu B, Kalem AK, et al
    Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
    J Antimicrob Chemother. 2023;78:1757-1768.
    >> Share

  152. GOLPARIAN D, Jacobsson S, Holley CL, Shafer WM, et al
    High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2023;78:1769-1778.
    >> Share

  153. GOMIS-FONT MA, Sastre-Femenia MA, Taltavull B, Cabot G, et al
    In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2023;78:1785-1794.
    >> Share

  154. RONDA M, Padulles A, Grau I, Tubau F, et al
    Impact of a prospective audit and feedback antimicrobial stewardship programme on carbapenem consumption: a quasi-experimental study (IPANEMA study).
    J Antimicrob Chemother. 2023;78:1705-1710.
    >> Share

  155. BROUWER MSM, Zandbergen Van Essen A, Kant A, Rapallini M, et al
    Implementation of WGS analysis of ESBL-producing Escherichia coli within EU AMR monitoring in livestock and meat.
    J Antimicrob Chemother. 2023;78:1701-1704.
    >> Share

  156. URUSHIBARA N, Aung MS, Kawaguchiya M, Ohashi N, et al
    Genome analysis of an SCCmec element in ST9-MRSA from Myanmar with a unique mec gene complex and two ccr gene complexes (ccrA1B1 and ccrA5B7).
    J Antimicrob Chemother. 2023;78:1805-1806.
    >> Share

  157. SORIANO A, Honore PM, Puerta-Alcalde P, Garcia-Vidal C, et al
    Invasive candidiasis: current clinical challenges and unmet needs in adult populations.
    J Antimicrob Chemother. 2023;78:1569-1585.
    >> Share

    June 2023
  158. YANG Q, Zhu Y, Schwarz S, Zhang W, et al
    Characterization of an optrA-harbouring unconventional circularizable structure located on a novel ICESa2603 family-like integrative and conjugative element ICESsuHN38 in Streptococcus suis.
    J Antimicrob Chemother. 2023 Jun 30:dkad205. doi: 10.1093.
    >> Share

  159. ANDO N, Mizushima D, Takano M, Mitobe M, et al
    Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study.
    J Antimicrob Chemother. 2023 Jun 28:dkad208. doi: 10.1093.
    >> Share

  160. DEPLANO A, Hallin M, Bustos Sierra N, Michel C, et al
    Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
    J Antimicrob Chemother. 2023 Jun 26:dkad204. doi: 10.1093.
    >> Share

  161. MARCHANDIN H, Anjou C, Poulen G, Freeman J, et al
    In vivo emergence of a still uncommon resistance to fidaxomicin in the urgent antimicrobial resistance threat Clostridioides difficile.
    J Antimicrob Chemother. 2023 Jun 23:dkad194. doi: 10.1093.
    >> Share

  162. KAKOOZA F, Golparian D, Matoga M, Maseko V, et al
    Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
    J Antimicrob Chemother. 2023 Jun 23:dkad193. doi: 10.1093.
    >> Share

  163. SIMJEE S, Tice G
    The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens.
    J Antimicrob Chemother. 2023 Jun 9:dkad183. doi: 10.1093.
    >> Share

  164. PIROLO M, Menezes M, Damborg P, Wegener A, et al
    In vitro and in vivo susceptibility to cefalexin and amoxicillin/clavulanate in canine low-level methicillin-resistant Staphylococcus pseudintermedius.
    J Antimicrob Chemother. 2023 Jun 9:dkad182. doi: 10.1093.
    >> Share

  165. NOWAKOWSKA J, Cameron DR, De Martino A, Kuhn J, et al
    Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin.
    J Antimicrob Chemother. 2023 Jun 9:dkad181. doi: 10.1093.
    >> Share

  166. CHEN Y, Sun L, Hong Y, Chen M, et al
    Exploring the third-generation tetracycline resistance of multidrug-resistant livestock-associated methicillin-resistant Staphylococcus aureus ST9 across healthcare settings in China.
    J Antimicrob Chemother. 2023 Jun 8:dkad174. doi: 10.1093.
    >> Share

  167. QIAN C, Ma Z, Feng L, Guo W, et al
    Emergence of tet(X2) in Acinetobacter pittii confers clinical resistance to tigecycline.
    J Antimicrob Chemother. 2023;78:1543-1546.
    >> Share

  168. GATTI M, Pea F
    Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2023;78:1556-1557.
    >> Share

  169. WORTMAN JM, Leegwater E, Van Lammeren-Venema D, Van Nieuwkoop C, et al
    Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment.
    J Antimicrob Chemother. 2023;78:1471-1475.
    >> Share

  170. DATTA S
    The conundrum of bacteria-specific antibiotics.
    J Antimicrob Chemother. 2023;78:1354-1358.
    >> Share

  171. SOJO-DORADO J, Lopez-Hernandez I, Hernandez-Torres A, Retamar-Gentil P, et al
    Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial.
    J Antimicrob Chemother. 2023 Jun 1:dkad147. doi: 10.1093.
    >> Share

    May 2023
  172. CINTHI M, Massacci FR, Coccitto SN, Albini E, et al
    Characterization of a prophage and a defective integrative conjugative element carrying the optrA gene in linezolid-resistant Streptococcus dysgalactiae subsp. equisimilis isolates from pigs, Italy.
    J Antimicrob Chemother. 2023 May 31:dkad164. doi: 10.1093.
    >> Share

  173. COCCITTO SN, Massacci FR, Cinthi M, Albini E, et al
    Co-location of the oxazolidinone resistance poxtA2 and cfr(D) genes on a multiresistance plasmid from a porcine Streptococcus dysgalactiae subsp. equisimilis, Italy.
    J Antimicrob Chemother. 2023 May 30:dkad169. doi: 10.1093.
    >> Share

  174. LALANNE S, Cattoir V, Guerin F, Verdier MC, et al
    Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo model.
    J Antimicrob Chemother. 2023 May 30:dkad155. doi: 10.1093.
    >> Share

  175. VASIKASIN V, Panuvatvanich B, Rawson TM, Holmes AH, et al
    Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
    J Antimicrob Chemother. 2023 May 30:dkad165. doi: 10.1093.
    >> Share

  176. SEALEY JE, Saunders R, Horspool T, Barrows MG, et al
    Molecular ecology of highest priority critically important antibiotic resistant Escherichia coli from mammals housed at an urban zoo.
    J Antimicrob Chemother. 2023 May 30:dkad148. doi: 10.1093.
    >> Share


  177. Correction to: Comparative effectiveness of beta-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
    J Antimicrob Chemother. 2023 May 23:dkad153. doi: 10.1093.
    >> Share

  178. SHEN W, Zhang R, Cai J
    Co-occurrence of multiple plasmid-borne linezolid resistance genes-optrA, cfr, poxtA2 and cfr(D) in an Enterococcus faecalis isolate from retail meat.
    J Antimicrob Chemother. 2023 May 20:dkad142. doi: 10.1093.
    >> Share

  179. SANDOVAL MM, Bardach A, Rojas-Roque C, Alconada T, et al
    Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.
    J Antimicrob Chemother. 2023 May 16:dkad071. doi: 10.1093.
    >> Share

  180. SCHELLENBERG JJ, Adam HJ, Baxter MR, Karlowsky JA, et al
    Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011-20.
    J Antimicrob Chemother. 2023;78.
    >> Share

  181. GOLDEN AR, Adam HJ, Karlowsky JA, Baxter M, et al
    Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    >> Share

  182. ADAM HJ, Karlowsky JA, Baxter MR, Schellenberg J, et al
    Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    >> Share

  183. ZHANEL GG, Lynch JP, Adam HJ
    Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
    J Antimicrob Chemother. 2023;78.
    >> Share

  184. ALFORD MA, Karlowsky JA, Adam HJ, Baxter MR, et al
    Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
    J Antimicrob Chemother. 2023;78.
    >> Share

  185. ELIAS R, Spadar A, Hendrickx APA, Bonnin RA, et al
    Emergence of KPC-3- and OXA-181-producing ST13 and ST17 Klebsiella pneumoniae in Portugal: genomic insights on national and international dissemination.
    J Antimicrob Chemother. 2023;78:1300-1308.
    >> Share

  186. SIMJEE S, Gould G, Maduro L, Boulianne M, et al
    No change in avilamycin (Surmax(R) Premix) minimum inhibitory concentration for Clostridium perfringens isolates recovered from poultry up to 7 years post-approval in Canada.
    J Antimicrob Chemother. 2023;78:1278-1281.
    >> Share

  187. GONZALEZ C, Volland H, Oueslati S, Niol L, et al
    Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:1282-1287.
    >> Share

  188. CASTILLO-POLO JA, Hernandez-Garcia M, Morosini MI, Perez-Viso B, et al
    Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime/avibactam and cefiderocol in a university hospital in Madrid, Spain.
    J Antimicrob Chemother. 2023;78:1259-1264.
    >> Share

  189. ALONSO-GARCIA I, Vazquez-Ucha JC, Lasarte-Monterrubio C, Gonzalez-Mayo E, et al
    Simultaneous and divergent evolution of resistance to cephalosporin/beta-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2023;78:1195-1200.
    >> Share

  190. JIA M, Zhou W, Luo D, Xue H, et al
    Calcium-binding motif-mediated binding of redundant calcium offers a chimeolysin enhanced bactericidal activity and extended host range under physiological conditions.
    J Antimicrob Chemother. 2023;78:1182-1190.
    >> Share

    April 2023
  191. DASHTBANI-ROOZBEHANI A, Chitsaz M, Brown MH
    The role of TMS 12 in the staphylococcal multidrug efflux protein QacA.
    J Antimicrob Chemother. 2023 Apr 26:dkad121. doi: 10.1093.
    >> Share

  192. DANESHNIA F, Hilmioglu-Polat S, Ilkit M, Fuentes D, et al
    Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis.
    J Antimicrob Chemother. 2023 Apr 26:dkad112. doi: 10.1093.
    >> Share

  193. HENDERSON A, Cheng MP, Chew KL, Coombs GW, et al
    A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus.
    J Antimicrob Chemother. 2023 Apr 18:dkad116. doi: 10.1093.
    >> Share

  194. BEREDAKI MI, Arendrup MC, Andes D, Meletiadis J, et al
    Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints.
    J Antimicrob Chemother. 2023 Apr 18:dkad096. doi: 10.1093.
    >> Share

  195. LAFAURIE M, Montlahuc C, Kerneis S, de Lastours V, et al
    Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
    J Antimicrob Chemother. 2023 Apr 4:dkad083. doi: 10.1093.
    >> Share

  196. SALEHI M, Farbod F, Khalili H, Rahmani H, et al
    Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial.
    J Antimicrob Chemother. 2023;78:1084-1091.
    >> Share

  197. LU B, Wong M, Ha D, Bounthavong M, et al
    Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
    J Antimicrob Chemother. 2023;78:1009-1014.
    >> Share

  198. KUFEL WD, Hitchcock AM, Delbalso AN, Paolino KM, et al
    Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance.
    J Antimicrob Chemother. 2023;78:1127-1128.
    >> Share

  199. SPERNOVASILIS N, Kritsotakis EI, Mathioudaki A, Vouidaski A, et al
    A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria.
    J Antimicrob Chemother. 2023;78:1000-1008.
    >> Share

    March 2023
  200. DIERIKX C, Hengeveld P, Witteveen S, van Hoek A, et al
    Genomic comparison of mecC-carrying methicillin-resistant Staphylococcus aureus from hedgehogs and humans in the Netherlands.
    J Antimicrob Chemother. 2023 Mar 30:dkad047. doi: 10.1093.
    >> Share

  201. CAREY GB, Holleck JL, Ein Alshaeba S, Jayakrishnan R, et al
    Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2023 Mar 25:dkad078. doi: 10.1093.
    >> Share

  202. KIME L, Waring T, Mohamad M, Mann BF, et al
    Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis.
    J Antimicrob Chemother. 2023 Mar 20:dkad063. doi: 10.1093.
    >> Share

  203. YAMAGUCHI R, Yamamoto T, Okamoto K, Harada S, et al
    Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study.
    J Antimicrob Chemother. 2023 Mar 15:dkad079. doi: 10.1093.
    >> Share

  204. BUIS DTP, van der Vaart TW, Prins JM, van der Meer JTM, et al
    Comparative effectiveness of beta-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
    J Antimicrob Chemother. 2023 Mar 10:dkad057. doi: 10.1093.
    >> Share

  205. WATKINS RR, Thapaliya D, Lemonovich TL, Bonomo RA, et al
    Gepotidacin: a novel, oral, 'first-in-class' triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea.
    J Antimicrob Chemother. 2023 Mar 8:dkad060. doi: 10.1093.
    >> Share

  206. SPADARI CC, Lanser DM, Araujo MV, De Jesus DFF, et al
    Oral delivery of brain-targeted miltefosine-loaded alginate nanoparticles functionalized with polysorbate 80 for the treatment of cryptococcal meningitis.
    J Antimicrob Chemother. 2023 Mar 7:dkad053. doi: 10.1093.
    >> Share

  207. HEIL EL, Claeys KC, Kline EG, Rogers TM, et al
    Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
    J Antimicrob Chemother. 2023 Mar 3:dkad042. doi: 10.1093.
    >> Share

  208. ESCUDERO-SANCHEZ R, Rubio Martin E, Vizcarra P, Braojos Sanchez F, et al
    Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis.
    J Antimicrob Chemother. 2023;78:823-827.
    >> Share

  209. MCCURDY S, Halasohoris SA, Babyak AL, Lembirik S, et al
    Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.
    J Antimicrob Chemother. 2023;78:810-816.
    >> Share

  210. DING ZH, Huang Y, Chen JN, Luo LS, et al
    A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.
    J Antimicrob Chemother. 2023;78:828-831.
    >> Share

  211. FRESAN D, Luque S, Benitez-Cano A, Sorli L, et al
    Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
    J Antimicrob Chemother. 2023;78:678-683.
    >> Share

  212. NUNN R, Clifford C, Merali Z
    Successful treatment of recurrent Clostridioides difficile infection by administration of crushed fidaxomicin via gastro-jejunal tube.
    J Antimicrob Chemother. 2023;78:850-851.
    >> Share

    February 2023
  213. GUO Y, Han R, Zhang G, Yang Q, et al
    Setting of the tentative epidemiological cut-off values of contezolid for Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, Streptococcus pneumoniae and Streptococcus agalactiae.
    J Antimicrob Chemother. 2023 Feb 28:dkad045. doi: 10.1093.
    >> Share

  214. KANEKO H, Yanagi Y, Otake S, Sato M, et al
    The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton-Valentine leucocidin and toxic shock syndrome toxin 1 genes.
    J Antimicrob Chemother. 2023 Feb 23:dkad039. doi: 10.1093.
    >> Share

  215. GUMBO T, Srivastava S, Deshpande D, Pasipanodya JG, et al
    Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
    J Antimicrob Chemother. 2023 Feb 16:dkad029. doi: 10.1093.
    >> Share

  216. BELLOUARD R, Rambaud A, Delaunay C, Dailly E, et al
    Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
    J Antimicrob Chemother. 2023 Feb 10:dkad030. doi: 10.1093.
    >> Share

  217. MORENO-MINGORANCE A, Mir-Cros A, Goterris L, Rodriguez-Garrido V, et al
    Increasing trend of antimicrobial resistance in Shigella associated with MSM transmission in Barcelona, 2020-21: outbreak of XRD Shigella sonnei and dissemination of ESBL-producing Shigella flexneri.
    J Antimicrob Chemother. 2023 Feb 10:dkad031. doi: 10.1093.
    >> Share

  218. CHEN H, Tao S, Li N, Zhu Q, et al
    Anti-restriction protein ArdA promotes clinical Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae spread and its molecular mechanism.
    J Antimicrob Chemother. 2023;78:521-530.
    >> Share

  219. BAE S, Kim ES, Lee YW, Jung J, et al
    Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia.
    J Antimicrob Chemother. 2023;78:531-539.
    >> Share

  220. YOUENOU B, Martins Simoes P, Tristan A, Farfour E, et al
    Linezolid resistance: detection of the cfr(B) gene in French clinical MRSA strains.
    J Antimicrob Chemother. 2023;78:445-449.
    >> Share

  221. LI Y, Liu Q, She J, Qiu Y, et al
    IS26-mediated in vivo acquisition of blaKPC-2 in an ST11-K64 Klebsiella pneumoniae isolate from a senile inpatient.
    J Antimicrob Chemother. 2023;78:550-553.
    >> Share

  222. VALLEE M, Harding C, Hall J, Aldridge PD, et al
    Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates.
    J Antimicrob Chemother. 2023;78:373-379.
    >> Share

    January 2023
  223. HU J, Chen L, Li G, Pan Y, et al
    Prevalence and genetic characteristics of fosB-positive Staphylococcus aureus in duck farms in Guangdong, China in 2020.
    J Antimicrob Chemother. 2023 Jan 24:dkad014. doi: 10.1093.
    >> Share

  224. ROBSON C, Tan B, Stuart R, Nicholls S, et al
    A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis.
    J Antimicrob Chemother. 2023 Jan 24:dkad005. doi: 10.1093.
    >> Share

  225. CHEN L, Hua J, Hong SJ, Yuan CY, et al
    Comparison of the relative efficacy of beta-lactam/beta-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational coh
    J Antimicrob Chemother. 2023 Jan 24:dkac448. doi: 10.1093.
    >> Share

  226. LI XX, Zhang FQ, Wang S, Duan XC, et al
    Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection.
    J Antimicrob Chemother. 2023 Jan 20:dkad006. doi: 10.1093.
    >> Share

  227. AL JANABI J, Tevell S, Sieber RN, Stegger M, et al
    Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections.
    J Antimicrob Chemother. 2023 Jan 6:dkac434. doi: 10.1093.
    >> Share

    December 2022
  228. POUGET C, Pantel A, Dunyach-Remy C, Magnan C, et al
    Antimicrobial activity of antibiotics on biofilm formed by Staphylococcus aureus and Pseudomonas aeruginosa in an open microfluidic model mimicking the diabetic foot environment.
    J Antimicrob Chemother. 2022 Dec 28:dkac438. doi: 10.1093.
    >> Share

  229. ZENG W, Han Y, Zheng X, Yao Z, et al
    Evaluation of resazurin microplate method for rapid detection of vancomycin and linezolid resistance in Enterococcus faecalis and Enterococcus faecium clinical isolates.
    J Antimicrob Chemother. 2022 Dec 28:dkac415. doi: 10.1093.
    >> Share

  230. BISHOP EJ, Tiruvoipati R
    Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    J Antimicrob Chemother. 2022;78:21-30.
    >> Share

  231. FRIMODT-MOLLER N, Simonsen GS, Larsen AR, Kahlmeter G, et al
    Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption.
    J Antimicrob Chemother. 2022;78:289-295.
    >> Share

  232. MAUCK CK, Atiee GJ, McCulloh J, Reynolds L, et al
    A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis.
    J Antimicrob Chemother. 2022;78:257-262.
    >> Share

  233. WU K, Wang J, Feng H, Li R, et al
    Complete genome sequence and characterization of Clostridium perfringens type D carrying optrA-plasmid and Tn6218-like transposon.
    J Antimicrob Chemother. 2022;78:311-313.
    >> Share

  234. ZHAO B, Han H, He K, Hou WF, et al
    Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli.
    J Antimicrob Chemother. 2022;78:216-224.
    >> Share

  235. ABD ALGAFFAR SO, Verbon A, Khalid SA, van de Sande WWJ, et al
    Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
    J Antimicrob Chemother. 2022;78:155-160.
    >> Share

  236. GOLPARIAN D, Jacobsson S, Sanchez-Buso L, Bazzo ML, et al
    GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility.
    J Antimicrob Chemother. 2022;78:150-154.
    >> Share

  237. MANTZOURANI E, Wasag D, Cannings-John R, Ahmed H, et al
    Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records.
    J Antimicrob Chemother. 2022;78:84-92.
    >> Share

  238. ANTONELLO RM, Canetti D, Riccardi N
    Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review.
    J Antimicrob Chemother. 2022;78:52-77.
    >> Share

  239. WAN TW, Yeo HH, Lee TF, Huang YT, et al
    Molecular epidemiology of bacteraemic vancomycin-resistant Enterococcus faecium isolates and in vitro activities of SC5005 and other comparators against these isolates collected from a medical centre in northern Taiwan, 2019-2020.
    J Antimicrob Chemother. 2022 Dec 17:dkac414. doi: 10.1093.
    >> Share

  240. XUAN H, Xia L, Schwarz S, Jia H, et al
    Various mobile genetic elements carrying optrA in Enterococcus faecium and Enterococcus faecalis isolates from swine within the same farm.
    J Antimicrob Chemother. 2022 Dec 12:dkac421. doi: 10.1093.
    >> Share

  241. XIAO J, Huang J, Xue X, Wang C, et al
    Novel cassette chromosome recombinases CcrA8B9 catalyse the excision and integration of the staphylococcal cassette chromosome mec element.
    J Antimicrob Chemother. 2022 Dec 8:dkac410. doi: 10.1093.
    >> Share

    November 2022
  242. LE MOIGNE V, Blouquit-Laye S, Desquesnes A, Girard-Misguich F, et al
    Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells.
    J Antimicrob Chemother. 2022;77:3496-3503.
    >> Share

  243. MAXWELL DN, Kim J, Pybus CA, White L, et al
    Clinically undetected polyclonal heteroresistance among Pseudomonas aeruginosa isolated from cystic fibrosis respiratory specimens.
    J Antimicrob Chemother. 2022;77:3321-3330.
    >> Share

  244. SPRUTE R, Grothe JH, Heringer S, Cornely OA, et al
    Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis.
    J Antimicrob Chemother. 2022;77:3475-3481.
    >> Share

  245. WU YE, Zhao W
    'Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants'-authors' response.
    J Antimicrob Chemother. 2022;77:3525-3526.
    >> Share

  246. CHEN L, Peirano G, Kreiswirth BN, Devinney R, et al
    Acquisition of genomic elements were pivotal for the success of Escherichia coli ST410.
    J Antimicrob Chemother. 2022;77:3399-3407.
    >> Share

  247. PAPAFOTIOU C, Roussos S, Sypsa V, Bampali S, et al
    Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area.
    J Antimicrob Chemother. 2022;77:3331-3339.
    >> Share

  248. BIEDRZYCKA M, Izdebski R, Urbanowicz P, Polanska M, et al
    MDR carbapenemase-producing Klebsiella pneumoniae of the hypervirulence-associated ST23 clone in Poland, 2009-19.
    J Antimicrob Chemother. 2022;77:3367-3375.
    >> Share

  249. VIANA AS, Botelho AMN, Feder A, Moustafa AM, et al
    High frequency of increased triclosan MIC among CC5 MRSA and risk of misclassification of the SCCmec into types.
    J Antimicrob Chemother. 2022;77:3340-3348.
    >> Share

  250. ZHANG W, Ran J, Shang L, Zhang L, et al
    Niclosamide as a repurposing drug against Gram-positive bacterial infections.
    J Antimicrob Chemother. 2022;77:3312-3320.
    >> Share

  251. IMANI S, Fitzgerald DA, Robinson PD, Selvadurai H, et al
    Personalized tobramycin dosing in children with cystic fibrosis: a comparative clinical evaluation of log-linear and Bayesian methods.
    J Antimicrob Chemother. 2022;77:3358-3366.
    >> Share

  252. STANDING JF
    Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
    J Antimicrob Chemother. 2022;77:3524.
    >> Share

  253. HOENIGL M, Lewis R, van de Veerdonk FL, Verweij PE, et al
    Liposomal amphotericin B-the future.
    J Antimicrob Chemother. 2022;77.
    >> Share

  254. BRUGGEMANN RJ, Jensen GM, Lass-Florl C
    Liposomal amphotericin B-the past.
    J Antimicrob Chemother. 2022;77.
    >> Share

  255. MAERTENS J, Pagano L, Azoulay E, Warris A, et al
    Liposomal amphotericin B-the present.
    J Antimicrob Chemother. 2022;77.
    >> Share

  256. GILL CM, Nicolau DP
    Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022 Nov 22:dkac385. doi: 10.1093.
    >> Share

  257. LALANNE S, Guerin F, Flecher E, Cattoir V, et al
    Diffusion of amoxicillin into heart valves from infective endocarditis patients.
    J Antimicrob Chemother. 2022 Nov 15. pii: 6827952. doi: 10.1093.
    >> Share

  258. SARAVOLATZ LD, Pawlak J
    In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    J Antimicrob Chemother. 2022 Nov 14. pii: 6827318. doi: 10.1093.
    >> Share

  259. SPRUTE R, Van Braeckel E, Flick H, Hoenigl M, et al
    EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis.
    J Antimicrob Chemother. 2022 Nov 14. pii: 6827316. doi: 10.1093.
    >> Share

  260. EVANS RN, Harris J, Rogers CA, Macgowan AP, et al
    The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO).
    J Antimicrob Chemother. 2022 Nov 8. pii: 6811497. doi: 10.1093.
    >> Share

  261. CASTRO BE, Rios R, Carvajal LP, Vargas ML, et al
    Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794061. doi: 10.1093.
    >> Share

  262. KELENTSE N, Moyo S, Choga WT, Lechiile K, et al
    High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana.
    J Antimicrob Chemother. 2022 Nov 2. pii: 6794066. doi: 10.1093.
    >> Share

    October 2022
  263. TRIPONNEY P, Bour M, Beyrouthy R, Bonnet R, et al
    Role of megaplasmids and chromosomal integration in acquisition of CTX-M-encoding genes by Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:3194-3198.
    >> Share

  264. WITT LS, Burd EM, Ozturk T, Satola SW, et al
    'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.
    J Antimicrob Chemother. 2022;77:3212.
    >> Share

  265. NOTERMANS DW, Schoffelen AF, Landman F, Wielders CCH, et al
    A genetic cluster of OXA-244 carbapenemase-producing Escherichia coli ST38 with putative uropathogenicity factors in the Netherlands.
    J Antimicrob Chemother. 2022;77:3205-3208.
    >> Share

  266. LASKO MJ, Tabor-Rennie JL, Nicolau DP, Kuti JL, et al
    Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
    J Antimicrob Chemother. 2022;77:3187-3193.
    >> Share

  267. HERNANDEZ-GARCIA M, Garcia-Castillo M, Melo-Cristino J, Pinto MF, et al
    In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies).
    J Antimicrob Chemother. 2022;77:3163-3172.
    >> Share

  268. TAM VH, Merlau PR, Hudson CS, Kline EG, et al
    Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:3130-3137.
    >> Share

  269. SUMI CD, Heffernan AJ, Naicker S, Cottrell K, et al
    Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates.
    J Antimicrob Chemother. 2022;77:3026-3034.
    >> Share

  270. PITT R, Boampong D, Day M, Jensen JS, et al
    Challenges of in vitro propagation and antimicrobial susceptibility testing of Mycoplasma genitalium.
    J Antimicrob Chemother. 2022;77:2901-2907.
    >> Share

  271. ZHAO X, Huang H, Yuan H, Yuan Z, et al
    A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response.
    J Antimicrob Chemother. 2022;77:3210-3211.
    >> Share

  272. BRUNA RE, Casal A, Bercovich B, Gramajo H, et al
    A natural product from Streptomyces targets PhoP and exerts antivirulence action against Salmonella enterica.
    J Antimicrob Chemother. 2022;77:3050-3063.
    >> Share

  273. WANG PL, Liu P, Zhang QW, Yuan WH, et al
    Population pharmacokinetics and clinical outcomes of polymyxin B in paediatric patients with multidrug-resistant Gram-negative bacterial infections.
    J Antimicrob Chemother. 2022;77:3000-3008.
    >> Share

  274. PALKOVICOVA J, Sukkar I, Delafuente J, Valcek A, et al
    Fitness effects of blaCTX-M-15-harbouring F2:A1:B- plasmids on their native Escherichia coli ST131 H30Rx hosts.
    J Antimicrob Chemother. 2022;77:2960-2963.
    >> Share

  275. AYFAN AKS, Macdonald J, Irwin AD, Zowawi HM, et al
    Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    J Antimicrob Chemother. 2022;77:2933-2936.
    >> Share

  276. TANG K, Coombs S, Gwee A
    Frequency of drug-induced liver injury in children receiving anti-staphylococcal penicillins.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6751029. doi: 10.1093.
    >> Share

  277. DE JONG A, El Garch F, Hocquet D, Prenger-Berninghoff E, et al
    European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.
    J Antimicrob Chemother. 2022 Oct 7. pii: 6750681. doi: 10.1093.
    >> Share

    September 2022
  278. SHRESTHA R, Luterbach CL, Dai W, Komarow L, et al
    Characteristics of community-acquired carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022;77:2763-2771.
    >> Share

  279. GROHS P, Vilfaillot A, Zahar JR, Barbut F, et al
    Faecal carriage of multidrug-resistant bacteria and associated risk factors: results from a point prevalence study.
    J Antimicrob Chemother. 2022;77:2667-2678.
    >> Share

  280. BRENCIANI A, Morroni G, Schwarz S, Giovanetti E, et al
    Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
    J Antimicrob Chemother. 2022;77:2596-2621.
    >> Share

  281. VOLLAND H, Balleste-Delpierre C, Szabo D, Gonzalez C, et al
    Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool.
    J Antimicrob Chemother. 2022;77:2867-2875.
    >> Share

  282. LONGSHAW CM, Santerre Henriksen A, Slover C, Yamano Y, et al
    Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    J Antimicrob Chemother. 2022;77:2895-2896.
    >> Share

  283. PATEL S, Chapagain M, Mason C, Gingrich M, et al
    Potency of the novel PolC DNA polymerase inhibitor CRS0540 in a disseminated Listeria monocytogenes intracellular hollow-fibre model.
    J Antimicrob Chemother. 2022;77:2876-2885.
    >> Share

  284. LASARTE-MONTERRUBIO C, Fraile-Ribot PA, Vazquez-Ucha JC, Cabot G, et al
    Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:2809-2815.
    >> Share

  285. KADO J, Salman S, Hand R, O'Brien M, et al
    Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.
    J Antimicrob Chemother. 2022;77:2679-2682.
    >> Share

  286. DE LAUZANNE A, Sreng N, Foucaud E, Sok T, et al
    Prevalence and factors associated with faecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales among peripartum women in the community in Cambodia.
    J Antimicrob Chemother. 2022;77:2658-2666.
    >> Share

  287. DIAS SA, Pinto SN, Silva-Herdade AS, Cheneval O, et al
    A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms.
    J Antimicrob Chemother. 2022 Sep 29. pii: 6728340. doi: 10.1093.
    >> Share

  288. LI J, Fan Q, Zuo J, Xue B, et al
    Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection.
    J Antimicrob Chemother. 2022 Sep 28. pii: 6730836. doi: 10.1093.
    >> Share

  289. RAMPACCI E, Felicetti T, Pietrella D, Sabatini S, et al
    Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance.
    J Antimicrob Chemother. 2022 Sep 28. pii: 6730837. doi: 10.1093.
    >> Share

  290. MELENDEZ-CARMONA MA, Mancheno-Losa M, Ruiz-Sorribas A, Munoz-Gallego I, et al
    Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
    J Antimicrob Chemother. 2022 Sep 19. pii: 6704758. doi: 10.1093.
    >> Share

  291. COLOMBO AL, De Almeida JN, Lewis RE, Kontoyiannis DP, et al
    Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis.
    J Antimicrob Chemother. 2022 Sep 5. pii: 6691804. doi: 10.1093.
    >> Share

  292. RIGATTO MH, Ramos F, Barros A, Pedroso S, et al
    Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
    J Antimicrob Chemother. 2022 Sep 1. pii: 6681124. doi: 10.1093.
    >> Share

    August 2022
  293. DIAZ-GARCIA J, Gomez A, Machado M, Alcala L, et al
    Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris.
    J Antimicrob Chemother. 2022 Aug 29. pii: 6678135. doi: 10.1093.
    >> Share

  294. KONG FYS, Lo FWY, Hocking JS
    Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials-authors' response.
    J Antimicrob Chemother. 2022;77:2576-2577.
    >> Share

  295. GONZALEZ-DIAZ A, Berbel D, Ercibengoa M, Cercenado E, et al
    Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain.
    J Antimicrob Chemother. 2022;77:2389-2398.
    >> Share

  296. YAMADA K, Yoshizumi A, Nagasawa T, Aoki K, et al
    Molecular and biochemical characterization of novel PAM-like MBL variants, PAM-2 and PAM-3, from clinical isolates of Pseudomonas tohonis.
    J Antimicrob Chemother. 2022;77:2414-2418.
    >> Share

  297. PATERSON DL, Bassetti M, Motyl M, Johnson MG, et al
    Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.
    J Antimicrob Chemother. 2022;77:2522-2531.
    >> Share

  298. MULLALLY C, Stubbs KA, Thai VC, Anandan A, et al
    Novel small molecules that increase the susceptibility of Neisseria gonorrhoeae to cationic antimicrobial peptides by inhibiting lipid A phosphoethanolamine transferase.
    J Antimicrob Chemother. 2022;77:2441-2447.
    >> Share

  299. PECHACEK J, Yakubu I, Vissichelli NC, Bruno D, et al
    Successful expanded access use of rezafungin, a novel echinocandin, to eradicate refractory invasive candidiasis in a liver transplant recipient.
    J Antimicrob Chemother. 2022;77:2571-2573.
    >> Share

  300. YANG F, Gao S, Yan J, Lin X, et al
    Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model.
    J Antimicrob Chemother. 2022;77:2461-2469.
    >> Share

  301. PARET R, Le Bourgeois A, Guillerm G, Tessoulin B, et al
    Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
    J Antimicrob Chemother. 2022;77:2546-2556.
    >> Share

  302. HSU YP, Chen LF, Chen FL, Liu YK, et al
    Comment on: Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    J Antimicrob Chemother. 2022;77:2574-2576.
    >> Share

  303. WILSON RC, Arkell P, Riezk A, Gilchrist M, et al
    Addition of probenecid to oral beta-lactam antibiotics: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:2364-2372.
    >> Share

  304. WITT LS, Steed DB, Burd EM, Ozturk T, et al
    Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    J Antimicrob Chemother. 2022;77:2569-2571.
    >> Share

  305. ISLAM K, Sime FB, Wallis SC, Bauer MJ, et al
    Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum beta-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model.
    J Antimicrob Chemother. 2022;77:2448-2455.
    >> Share

  306. YOON CH, Bartlett S, Stoesser N, Pouwels KB, et al
    Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.
    J Antimicrob Chemother. 2022;77:2536-2545.
    >> Share

  307. ZHAO L, Liu A, Li R, Zhang Z, et al
    High prevalence of blaTEM-135 and genetic epidemiology of blaTEM-135-carrying Neisseria gonorrhoeae isolates in Shandong, China, 2017-19.
    J Antimicrob Chemother. 2022;77:2406-2413.
    >> Share

  308. DANJOU W, Chabert P, Perpoint T, Pradat P, et al
    Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period.
    J Antimicrob Chemother. 2022;77:2532-2535.
    >> Share

  309. WANG G, Wu P, Tang R, Zhang W, et al
    Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2022;77:2353-2363.
    >> Share

  310. NUESCH-INDERBINEN M, Biggel M, Zurfluh K, Treier A, et al
    Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667639. doi: 10.1093.
    >> Share

  311. FONG W, Timms V, Sim E, Pey K, et al
    Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
    J Antimicrob Chemother. 2022 Aug 16. pii: 6667673. doi: 10.1093.
    >> Share

  312. ESCOLA-VERGE L, Rello P, Declerck C, Dubee V, et al
    Infective endocarditis in pregnant women without intravenous drug use: a multicentre retrospective case series.
    J Antimicrob Chemother. 2022 Aug 13. pii: 6664295. doi: 10.1093.
    >> Share

    July 2022
  313. ROGERS TR, Verweij PE, Castanheira M, Dannaoui E, et al
    Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.
    J Antimicrob Chemother. 2022;77:2053-2073.
    >> Share

  314. GASTINE S, Hempel G, Neely MN, Walsh TJ, et al
    Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients.
    J Antimicrob Chemother. 2022;77:2209-2216.
    >> Share

  315. SALLEM N, Hammami A, Mnif B
    Trends in human intestinal carriage of ESBL- and carbapenemase-producing Enterobacterales among food handlers in Tunisia: emergence of C1-M27-ST131 subclades, blaOXA-48 and blaNDM.
    J Antimicrob Chemother. 2022;77:2142-2152.
    >> Share

  316. KAKU N, Sasaki D, Ota K, Miyazaki T, et al
    Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 2019.
    J Antimicrob Chemother. 2022;77:2130-2141.
    >> Share

  317. CHUANG YC, Lin HY, Yang JL, Lin CY, et al
    Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin.
    J Antimicrob Chemother. 2022;77:2278-2287.
    >> Share

  318. CHEN L, van Rhee KP, Wasmann RE, Krekels EHJ, et al
    Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults.
    J Antimicrob Chemother. 2022;77:2217-2226.
    >> Share

  319. ROSCA AS, Castro J, Sousa LGV, Franca A, et al
    In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence.
    J Antimicrob Chemother. 2022;77:2183-2190.
    >> Share

  320. KUFEL WD, Abouelhassan Y, Steele JM, Gutierrez RL, et al
    Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
    J Antimicrob Chemother. 2022 Jul 23. pii: 6648989. doi: 10.1093.
    >> Share

  321. BUIS DTP, Prins JM, Betica-Radic L, de Boer MGJ, et al
    Current clinical practice in antibiotic treatment of Staphylococcus aureus bacteraemia: results from a survey in five European countries.
    J Antimicrob Chemother. 2022 Jul 23. pii: 6648977. doi: 10.1093.
    >> Share

  322. SEALEY JE, Hammond A, Mounsey O, Gould VC, et al
    Molecular ecology and risk factors for third-generation cephalosporin-resistant Escherichia coli carriage by dogs living in urban and nearby rural settings.
    J Antimicrob Chemother. 2022 Jul 20. pii: 6645196. doi: 10.1093.
    >> Share

  323. CHEN T, Zhao L, Liu Y, Wang Y, et al
    Mechanisms of high-level fosfomycin resistance in Staphylococcus aureus epidemic lineage ST5.
    J Antimicrob Chemother. 2022 Jul 15. pii: 6644783. doi: 10.1093.
    >> Share

  324. EMERAUD C, Godmer A, Girlich D, Vanparis O, et al
    Activity of mecillinam against carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Jul 11. pii: 6639593. doi: 10.1093.
    >> Share

    June 2022
  325. TURNER NA, Xu A, Zaharoff S, Holland TL, et al
    Determination of plasma protein binding of dalbavancin.
    J Antimicrob Chemother. 2022;77:1899-1902.
    >> Share

  326. CHUMBITA M, Puerta-Alcalde P, Yanez L, Cuesta MA, et al
    Resistance to empirical beta-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
    J Antimicrob Chemother. 2022;77:2017-2023.
    >> Share

  327. TORRENS G, van der Schalk TE, Cortes-Lara S, Timbermont L, et al
    Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
    J Antimicrob Chemother. 2022;77:1862-1872.
    >> Share

  328. GOMEZ-SIMMONDS A, Annavajhala MK, Tang N, Rozenberg FD, et al
    Population structure of blaKPC-harbouring IncN plasmids at a New York City medical centre and evidence for multi-species horizontal transmission.
    J Antimicrob Chemother. 2022;77:1873-1882.
    >> Share

  329. ONG JJ, Aguirre I, Unemo M, Kong FYS, et al
    Comparison of gastrointestinal side effects from different doses of azithromycin for the treatment of gonorrhoea.
    J Antimicrob Chemother. 2022;77:2011-2016.
    >> Share

  330. ESCUDERO-SANCHEZ R, Muriel Garcia A, Garcia Fernandez S, Valencia Alijo A, et al
    Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
    J Antimicrob Chemother. 2022;77:1996-2002.
    >> Share

  331. DARLOW CA, Hope W
    Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.
    J Antimicrob Chemother. 2022;77:2047-2048.
    >> Share

  332. STANDING JF
    Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
    J Antimicrob Chemother. 2022;77:2046-2047.
    >> Share

  333. KAUL G, Akhir A, Shukla M, Rawat KS, et al
    Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo.
    J Antimicrob Chemother. 2022 Jun 24. pii: 6617327. doi: 10.1093.
    >> Share

  334. IQBAL K, Rohde H, Huang J, Tikiso T, et al
    A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.
    J Antimicrob Chemother. 2022 Jun 13. pii: 6607739. doi: 10.1093.
    >> Share

  335. GAUSI K, Chirehwa M, Ignatius EH, Court R, et al
    Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis.
    J Antimicrob Chemother. 2022 Jun 9. pii: 6604654. doi: 10.1093.
    >> Share

    May 2022
  336. VUILLEMENOT JB, Bour M, Beyrouthy R, Bonnet R, et al
    Genomic analysis of CTX-M-115 and OXA-23/-72 co-producing Acinetobacter baumannii, and their potential to spread resistance genes by natural transformation.
    J Antimicrob Chemother. 2022;77:1542-1552.
    >> Share

  337. GAIBANI P, Bovo F, Bussini L, Lazzarotto T, et al
    Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
    J Antimicrob Chemother. 2022;77:1570-1577.
    >> Share

  338. PORMOHAMMAD A, Greening D, Turner RJ
    Synergism inhibition and eradication activity of silver nitrate/potassium tellurite combination against Pseudomonas aeruginosa biofilm.
    J Antimicrob Chemother. 2022;77:1635-1644.
    >> Share

  339. SPRUTE R, Bethe U, Chen SC, Cornely OA, et al
    EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections.
    J Antimicrob Chemother. 2022;77:1779-1784.
    >> Share

  340. NAHA S, Sands K, Mukherjee S, Dutta S, et al
    A 12 year experience of colistin resistance in Klebsiella pneumoniae causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics.
    J Antimicrob Chemother. 2022;77:1586-1591.
    >> Share

  341. CABRERA R, Fernandez-Barat L, Vazquez N, Alcaraz-Serrano V, et al
    Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis.
    J Antimicrob Chemother. 2022;77:1600-1610.
    >> Share

  342. YEOH DK, Haeusler GM, McMullan BJ, Butters C, et al
    Antifungal use in children with acute leukaemia: state of current evidence and directions for future research.
    J Antimicrob Chemother. 2022;77:1508-1524.
    >> Share

  343. IZDEBSKI R, Biedrzycka M, Urbanowicz P, Papierowska-Kozdoj W, et al
    Multiple secondary outbreaks of NDM-producing Enterobacter hormaechei in the context of endemic NDM-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:1561-1569.
    >> Share

  344. JAUNEIKAITE E, Honeyford K, Blandy O, Mosavie M, et al
    Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
    J Antimicrob Chemother. 2022;77:1753-1761.
    >> Share

  345. CHAPAGAIN M, Pasipanodya JG, Athale S, Bernal C, et al
    Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses.
    J Antimicrob Chemother. 2022;77:1694-1705.
    >> Share

  346. LUQUE-PAZ D, Bennis Y, Jaubert P, Dubee V, et al
    Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis.
    J Antimicrob Chemother. 2022;77:1787-1789.
    >> Share

  347. SAKOULAS G
    Linezolid versus omadacycline in diabetic soft tissue infections: a signal of different adjunctive immunological properties?
    J Antimicrob Chemother. 2022;77:1503-1505.
    >> Share

  348. IWUJI C, Pillay D, Shamu P, Murire M, et al
    A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.
    J Antimicrob Chemother. 2022 May 17. pii: 6586623. doi: 10.1093.
    >> Share

  349. WILLEKENS R, Puig-Asensio M, Suanzes P, Fernandez-Hidalgo N, et al
    Empirical use of beta-lactam/beta-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
    J Antimicrob Chemother. 2022 May 12. pii: 6584695. doi: 10.1093.
    >> Share

  350. GOLPARIAN D, Kittiyaowamarn R, Paopang P, Sangprasert P, et al
    Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.
    J Antimicrob Chemother. 2022 May 11. pii: 6583486. doi: 10.1093.
    >> Share

    April 2022
  351. FLATEAU C, Riazi A, Cassard B, Camus M, et al
    Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?-authors' response.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574660. doi: 10.1093.
    >> Share

  352. GARCIA-FIERRO R, Drapeau A, Dazas M, Saras E, et al
    Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans.
    J Antimicrob Chemother. 2022;77:1263-1271.
    >> Share

  353. ABBOTT IJ, van Gorp E, Wyres KL, Wallis SC, et al
    Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.
    J Antimicrob Chemother. 2022;77:1324-1333.
    >> Share

  354. MILTGEN G, Martak D, Valot B, Kamus L, et al
    One Health compartmental analysis of ESBL-producing Escherichia coli on Reunion Island reveals partitioning between humans and livestock.
    J Antimicrob Chemother. 2022;77:1254-1262.
    >> Share

  355. BASTIDA C, Hernandez-Tejero M, Cariqueo M, Aziz F, et al
    Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections.
    J Antimicrob Chemother. 2022;77:1365-1371.
    >> Share

  356. MEI CY, Jiao X, Wu H, Wang ZY, et al
    Detection of cfr in Leclercia adecarboxylata from pig feed, China.
    J Antimicrob Chemother. 2022;77:1500-1502.
    >> Share

  357. ZHANG X, Shi S, Yao Z, Zheng X, et al
    Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574685. doi: 10.1093.
    >> Share

  358. TAIT JR, Barnett TC, Rogers KE, Lee WL, et al
    Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
    J Antimicrob Chemother. 2022 Apr 26. pii: 6573986. doi: 10.1093.
    >> Share

  359. LOPEZ-VARELA E, Abulfathi AA, Strydom N, Goussard P, et al
    Drug concentration at the site of disease in children with pulmonary tuberculosis.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573919. doi: 10.1093.
    >> Share

  360. CHAGNEAU CV, Alcouffe O, Grare M, Oswald E, et al
    Screening for beta-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573466. doi: 10.1093.
    >> Share

  361. ENER B, Ergin C, Gulmez D, Agca H, et al
    Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571734. doi: 10.1093.
    >> Share

  362. SCHWENDENER S, Perreten V
    The bla and mec families of beta-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571732. doi: 10.1093.
    >> Share

  363. LIU C, Dong N, Zeng Y, Lu J, et al
    Co-transfer of last-line antibiotic resistance and virulence operons by an IncFIBk-FII-X3-ColKP3 hybrid plasmid in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571571. doi: 10.1093.
    >> Share

  364. SIMOS PA, Holland DJ, Stewart A, Isler B, et al
    Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568605. doi: 10.1093.
    >> Share

  365. CORTES MF, Andre C, Martins Simoes P, Corvec S, et al
    Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureu
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568602. doi: 10.1093.
    >> Share

  366. FUCHS F, Becerra-Aparicio F, Xanthopoulou K, Seifert H, et al
    In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    J Antimicrob Chemother. 2022 Apr 12. pii: 6566767. doi: 10.1093.
    >> Share

  367. HARMER CJ, Lebreton F, Stam J, McGann PT, et al
    Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance.
    J Antimicrob Chemother. 2022 Apr 11. pii: 6566059. doi: 10.1093.
    >> Share

  368. GIULIANO S, Angelini J, Flammini S, Tascini C, et al
    Comment on: Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562960. doi: 10.1093.
    >> Share

  369. CHAIBEN V, Yamada CH, Telles JP, de Andrade AP, et al
    A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562691. doi: 10.1093.
    >> Share

    March 2022
  370. BIEZ L, Bonnin RA, Naas T, Dortet L, et al
    Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France.
    J Antimicrob Chemother. 2022;77:1200-1202.
    >> Share

  371. MUDDE SE, Upton AM, Lenaerts A, Bax HI, et al
    Delamanid or pretomanid? A Solomonic judgement!
    J Antimicrob Chemother. 2022;77:880-902.
    >> Share

  372. GOMIS-FONT MA, Cabot G, Lopez-Arguello S, Zamorano L, et al
    Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    J Antimicrob Chemother. 2022;77:957-968.
    >> Share

  373. PANT N, Wallis SC, Roberts JA, Eisen DP, et al
    In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation.
    J Antimicrob Chemother. 2022;77:1041-1044.
    >> Share

  374. EMERAUD C, Petit C, Gauthier L, Bonnin RA, et al
    Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 2018.
    J Antimicrob Chemother. 2022;77:944-951.
    >> Share

  375. REYNOLDS R, Mushtaq S, Allen MK, Horner C, et al
    Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
    J Antimicrob Chemother. 2022;77:1206-1208.
    >> Share

  376. FALCONE M, Tiseo G, Arcari G, Leonildi A, et al
    Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21.
    J Antimicrob Chemother. 2022;77:1140-1145.
    >> Share

  377. WANG W, Hu Y, Baker M, Dottorini T, et al
    Novel SCCmec type XV (7A) and two pseudo-SCCmec variants in foodborne MRSA in China.
    J Antimicrob Chemother. 2022;77:903-909.
    >> Share

  378. LI D, Li P, Peng M, Zhao X, et al
    Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli.
    J Antimicrob Chemother. 2022;77:952-956.
    >> Share

  379. MAGALLON A, Amoureux L, Garrigos T, Sonois M, et al
    Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans.
    J Antimicrob Chemother. 2022;77:926-929.
    >> Share

  380. MARTIN-LOECHES I, Timsit JF, Kollef MH, Wunderink RG, et al
    Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
    J Antimicrob Chemother. 2022;77:1166-1177.
    >> Share

  381. VEHRESCHILD MJGT, Ducher A, Louie T, Cornely OA, et al
    An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
    J Antimicrob Chemother. 2022;77:1155-1165.
    >> Share

  382. TICKNER JA, Bradshaw CS, Murray GL, Whiley DM, et al
    Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.
    J Antimicrob Chemother. 2022 Mar 30. pii: 6555777. doi: 10.1093.
    >> Share

  383. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    >> Share

  384. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    >> Share

  385. KIRCHHOFF L, Dittmer S, Furnica DT, Buer J, et al
    Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    J Antimicrob Chemother. 2022 Mar 15. pii: 6548677. doi: 10.1093.
    >> Share

  386. CREMANNS M, Lange F, Gatermann SG, Pfennigwerth N, et al
    Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Mar 10. pii: 6546017. doi: 10.1093.
    >> Share

  387. BATESON A, Ortiz Canseco J, McHugh TD, Witney AA, et al
    Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.
    J Antimicrob Chemother. 2022 Mar 9. pii: 6544883. doi: 10.1093.
    >> Share

  388. UPTON CM, Steele CI, Maartens G, Diacon AH, et al
    Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB).
    J Antimicrob Chemother. 2022 Mar 8. pii: 6543975. doi: 10.1093.
    >> Share

  389. NEVILLE LF, Shalit I, Warn PA, Rendell JT, et al
    Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
    J Antimicrob Chemother. 2022 Mar 1. pii: 6539950. doi: 10.1093.
    >> Share

    February 2022
  390. MELETIADIS J, Efstathiou I, van der Lee HAL, Astvad KMT, et al
    Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
    J Antimicrob Chemother. 2022 Feb 23. pii: 6534628. doi: 10.1093.
    >> Share

  391. BAE M, Jung J
    Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study-authors' response.
    J Antimicrob Chemother. 2022;77:859-860.
    >> Share

  392. BURY D, Wolfs TFW, Ter Heine R, Muilwijk EW, et al
    Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study.
    J Antimicrob Chemother. 2022;77:699-703.
    >> Share

  393. FOSTERVOLD A, Hetland MAK, Bakksjo R, Bernhoff E, et al
    A nationwide genomic study of clinical Klebsiella pneumoniae in Norway 2001-15: introduction and spread of ESBLs facilitated by clonal groups CG15 and CG307.
    J Antimicrob Chemother. 2022;77:665-674.
    >> Share

  394. ALIABADI S, Jauneikaite E, Muller-Pebody B, Hope R, et al
    Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study.
    J Antimicrob Chemother. 2022;77:782-792.
    >> Share

  395. HAGIYA H, Otsuka F
    Comment on: Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    J Antimicrob Chemother. 2022;77:857-858.
    >> Share

  396. MARTELLI F, AbuOun M, Cawthraw S, Storey N, et al
    Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom.
    J Antimicrob Chemother. 2022;77:846-848.
    >> Share

  397. LUO H, Chen W, Mai Z, Yang J, et al
    Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    J Antimicrob Chemother. 2022;77:656-664.
    >> Share

  398. FIFER H, Schaefer U, Pitt R, Allen H, et al
    Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepancies.
    J Antimicrob Chemother. 2022;77:849-850.
    >> Share

  399. KELLY J, Tysall L, Dewar S
    Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528651. doi: 10.1093.
    >> Share

  400. CHUANG YC, Tseng TC, Wang JT, Lin CY, et al
    Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525717. doi: 10.1093.
    >> Share

  401. GOLDEN AR, Baxter M, Adam HJ, Martin I, et al
    PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525856. doi: 10.1093.
    >> Share

  402. XU C, Wang N, Li D, Schwarz S, et al
    Recombination events that occur in a poxtA-carrying Enterococcus faecium during the conjugation process.
    J Antimicrob Chemother. 2022 Feb 8. pii: 6524123. doi: 10.1093.
    >> Share

  403. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2022;77:331-337.
    >> Share

  404. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2022;77:338-344.
    >> Share

  405. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2022;77:320-330.
    >> Share

  406. WASSERMAN S, Brust JCM, Abdelwahab MT, Little F, et al
    Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study.
    J Antimicrob Chemother. 2022 Feb 2. pii: 6520540. doi: 10.1093.
    >> Share

  407. SCHUSTER CF, Weber RE, Weig M, Werner G, et al
    Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243.
    J Antimicrob Chemother. 2022;77:381-390.
    >> Share

  408. GUO CG, Jiang F, Cheung KS, Li B, et al
    Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study.
    J Antimicrob Chemother. 2022;77:517-523.
    >> Share

  409. KANESAKA I, Ohno A, Katsuse AK, Takahashi H, et al
    The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance.
    J Antimicrob Chemother. 2022;77:364-373.
    >> Share

  410. LIN EY, Adamson PC, Klausner JD
    Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands.
    J Antimicrob Chemother. 2022;77:534-536.
    >> Share

    January 2022
  411. AMBROSE SJ, Evans BA, Hall RM
    Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
    J Antimicrob Chemother. 2022 Jan 30. pii: 6517523. doi: 10.1093.
    >> Share

  412. KIESWETTER NS, Ozturk M, Hlaka L, Chia JE, et al
    Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515318. doi: 10.1093.
    >> Share

  413. ZOU G, Matuszewska M, Bai F, Wang S, et al
    Genomic analyses of Staphylococcus aureus isolated from yaks in Ganzi Tibetan Autonomous Prefecture, China.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515324. doi: 10.1093.
    >> Share

  414. FRENK S, Temkin E, Lurie-Weinberger MN, Keren-Paz A, et al
    Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515327. doi: 10.1093.
    >> Share

  415. SEMPERE J, Gonzalez-Camacho F, Domenech M, Llamosi M, et al
    A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.
    J Antimicrob Chemother. 2022 Jan 19. pii: 6511705. doi: 10.1093.
    >> Share

  416. PAUNKOV A, Gutenbrunner K, Soki J, Leitsch D, et al
    Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.
    J Antimicrob Chemother. 2022 Jan 18. pii: 6510936. doi: 10.1093.
    >> Share

  417. MANTZOURANI E, Cannings-John R, Evans A, Ahmed H, et al
    To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy.
    J Antimicrob Chemother. 2022 Jan 17. pii: 6509366. doi: 10.1093.
    >> Share

  418. GWEE A, Duffull SB, Daley AJ, Lim M, et al
    Identifying a therapeutic target for vancomycin against staphylococci in young infants.
    J Antimicrob Chemother. 2022 Jan 17. pii: 6509364. doi: 10.1093.
    >> Share

  419. THILL P, Robineau O, Roosen G, Patoz P, et al
    Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections.
    J Antimicrob Chemother. 2022 Jan 13. pii: 6506691. doi: 10.1093.
    >> Share

  420. GAILLARD T, Dupieux-Chabert C, Butin M, Dumitrescu O, et al
    Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503862. doi: 10.1093.
    >> Share

    December 2021
  421. KLAUKE P, Schwab F, Gastmeier P, Maechler F, et al
    The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case-control study.
    J Antimicrob Chemother. 2021;77:229-236.
    >> Share

  422. FISCHER N, Maex M, Mattheus W, Van den Bossche A, et al
    Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19).
    J Antimicrob Chemother. 2021;77:89-97.
    >> Share

  423. TIMMERMANS M, Bogaerts B, Vanneste K, De Keersmaecker SCJ, et al
    Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.
    J Antimicrob Chemother. 2021;77:49-57.
    >> Share

  424. DE CARVALHO CCCR, Taglialegna A, Rosato AE
    Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated beta-lactam sensitization in clinical MRSA strains.
    J Antimicrob Chemother. 2021;77:135-147.
    >> Share

  425. YOON EJ, Kim HS, Woo H, Choi YJ, et al
    Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    J Antimicrob Chemother. 2021;77:69-73.
    >> Share

  426. BAE M, Jeong Y, Bae S, Kim MJ, et al
    Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    J Antimicrob Chemother. 2021;77:223-228.
    >> Share

  427. BUCKLEY AM, Moura IB, Altringham J, Ewin D, et al
    The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection.
    J Antimicrob Chemother. 2021;77:148-154.
    >> Share

  428. CAMERON-MCDERMOTT SM, Barrow GJ, Webster AM, De La Haye CO, et al
    Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
    J Antimicrob Chemother. 2021;77:218-222.
    >> Share

  429. WILLEMS RPJ, van Dijk K, Dierikx CM, Twisk JWR, et al
    Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study.
    J Antimicrob Chemother. 2021;77:237-245.
    >> Share

  430. STEMLER J, Lackner M, Chen SC, Hoenigl M, et al
    EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.
    J Antimicrob Chemother. 2021;77:253-258.
    >> Share

  431. NURJADI D, Klein S, Hannesen J, Heeg K, et al
    Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
    J Antimicrob Chemother. 2021;77:38-48.
    >> Share

  432. JIAN Y, Li T, Zhao L, Zhao N, et al
    Regulation of bla system in ST59-related oxacillin-susceptible mecA-positive Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Dec 16. pii: 6464066. doi: 10.1093.
    >> Share

  433. CINTHI M, Coccitto SN, Fioriti S, Morroni G, et al
    Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463073. doi: 10.1093.
    >> Share

  434. SHANG Y, Lv P, Su D, Li Y, et al
    Evolutionary conservative analysis revealed novel functional sites in the efflux pump NorA of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463078. doi: 10.1093.
    >> Share

  435. PIRES J, Huisman JS, Bonhoeffer S, Van Boeckel TP, et al
    Increase in antimicrobial resistance in Escherichia coli in food animals between 1980 and 2018 assessed using genomes from public databases.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459599. doi: 10.1093.
    >> Share

  436. HOLLAND M, Bjanes E, Nizet V, Dillon N, et al
    Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459101. doi: 10.1093.
    >> Share

  437. CEBALLOS-GARZON A, Monteoliva L, Gil C, Alvarez-Moreno C, et al
    Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459103. doi: 10.1093.
    >> Share

  438. DIAZ-DIAZ S, Recacha E, Garcia-Duque A, Docobo-Perez F, et al
    Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.
    J Antimicrob Chemother. 2021 Dec 8. pii: 6456190. doi: 10.1093.
    >> Share

    November 2021
  439. CHEUNG CY, McNeil MB, Cook GM
    Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection.
    J Antimicrob Chemother. 2021 Nov 28. pii: 6445137. doi: 10.1093.
    >> Share

  440. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2021 Nov 23. pii: 6433473. doi: 10.1093.
    >> Share

  441. WILCOX MH, Dryden M
    Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.
    J Antimicrob Chemother. 2021;76.
    >> Share

  442. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427455. doi: 10.1093.
    >> Share

  443. MYLONA E, Voong Vinh P, Qureshi S, Karkey A, et al
    Tebipenem as an oral alternative for the treatment of typhoid caused by XDR Salmonella Typhi.
    J Antimicrob Chemother. 2021;76:3197-3200.
    >> Share

  444. AL-MIR H, Osman M, Drapeau A, Hamze M, et al
    Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon.
    J Antimicrob Chemother. 2021;76:3135-3143.
    >> Share

  445. ZHANG S, Liu P, Wang Y, Shen Z, et al
    Multiresistance gene cfr(C) in Clostridium perfringens of cattle origin from China.
    J Antimicrob Chemother. 2021;76:3310-3312.
    >> Share

  446. BOOSTROM I, Bala Y, Vasic JM, Gluvakov J, et al
    Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial.
    J Antimicrob Chemother. 2021;76:3175-3182.
    >> Share

  447. LO FWY, Kong FYS, Hocking JS
    Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    J Antimicrob Chemother. 2021;76:3111-3124.
    >> Share

  448. SHASKOLSKIY B, Kandinov I, Kravtsov D, Filippova M, et al
    Prediction of ceftriaxone MIC in Neisseria gonorrhoeae using DNA microarray technology and regression analysis.
    J Antimicrob Chemother. 2021;76:3151-3158.
    >> Share

  449. HEARD F, Sehgal A
    Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?
    J Antimicrob Chemother. 2021;76:3071-3072.
    >> Share

  450. RAUWOLF KK, Hoertnagl C, Lass-Floerl C, Groll AH, et al
    Interaction in vitro of pulmonary surfactant with antifungal agents used for treatment and prevention of invasive aspergillosis.
    J Antimicrob Chemother. 2021 Nov 11. pii: 6425642. doi: 10.1093.
    >> Share

  451. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    >> Share

  452. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    >> Share

    October 2021
  453. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    >> Share

  454. JEN FE, El-Deeb IM, Zalucki YM, Edwards JL, et al
    A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides.
    J Antimicrob Chemother. 2021;76:2850-2853.
    >> Share

  455. BORTOLAIA V, Ronco T, Romascu L, Nicorescu I, et al
    Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    J Antimicrob Chemother. 2021;76:3063-3065.
    >> Share

  456. ADACHI F, Sekizuka T, Yamato M, Fukuoka K, et al
    Characterization of FRI carbapenemase-producing Enterobacter spp. isolated from a hospital and the environment in Osaka, Japan.
    J Antimicrob Chemother. 2021;76:3061-3062.
    >> Share

  457. GOLDEN AR, Karlowsky JA, Walkty A, Baxter MR, et al
    Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
    J Antimicrob Chemother. 2021;76:2825-2832.
    >> Share

  458. KARLOWSKY JA, Walkty A, Golden AR, Baxter MR, et al
    ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
    J Antimicrob Chemother. 2021;76:2815-2824.
    >> Share

  459. ZAHR N, Urien S, Aubry A, Chauvin C, et al
    Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections.
    J Antimicrob Chemother. 2021;76:2906-2913.
    >> Share

  460. RING K, Shiva F
    Comment on: Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis.
    J Antimicrob Chemother. 2021;76:3067-3068.
    >> Share

  461. ADAMSON PC, Lin EY, Ha SM, Klausner JD, et al
    Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    J Antimicrob Chemother. 2021;76:2847-2849.
    >> Share

  462. GOLDSTEIN E
    Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings.
    J Antimicrob Chemother. 2021;76:2745-2747.
    >> Share

  463. CHARRET L, Bart G, Hoppe E, Dernis E, et al
    Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study.
    J Antimicrob Chemother. 2021;76:3029-3032.
    >> Share

    September 2021
  464. ENGBERG J, Vejrum LK, Madsen TV, Nielsen XC, et al
    Verification of analytical bacterial spectrum of QIAstat-Dx(R) GI V2 and Novodiag(R) Bacterial GE+ V2-0 diagnostic panels.
    J Antimicrob Chemother. 2021;76.
    >> Share

  465. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    >> Share

  466. DIEZ-AGUILAR M, Ekkelenkamp M, Morosini MI, Huertas N, et al
    Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:2578-2585.
    >> Share

  467. SASS G, Larwood DJ, Martinez M, Shrestha P, et al
    Efficacy of nikkomycin Z in murine CNS coccidioidomycosis: modelling sustained-release dosing.
    J Antimicrob Chemother. 2021;76:2629-2635.
    >> Share

  468. GEBREMARIAM T, Gu Y, Singh S, Kitt TM, et al
    Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
    J Antimicrob Chemother. 2021;76:2636-2639.
    >> Share

  469. DARAGON B, Fournier D, Plesiat P, Jeannot K, et al
    Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021;76:2586-2592.
    >> Share

  470. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    >> Share

  471. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    >> Share

  472. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    >> Share

  473. RAISANEN K, Sarvikivi E, Arifulla D, Pietikainen R, et al
    Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20.
    J Antimicrob Chemother. 2021;76:2697-2701.
    >> Share

  474. BIEDRZYCKA M, Urbanowicz P, Guzek A, Brisse S, et al
    Dissemination of Klebsiella pneumoniae ST147 NDM-1 in Poland, 2015-19.
    J Antimicrob Chemother. 2021;76:2538-2545.
    >> Share

  475. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    >> Share

    August 2021
  476. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    >> Share

  477. URBANOWICZ P, Izdebski R, Baraniak A, Zabicka D, et al
    Molecular and genomic epidemiology of VIM/IMP-like metallo-beta-lactamase-producing Pseudomonas aeruginosa genotypes in Poland.
    J Antimicrob Chemother. 2021;76:2273-2284.
    >> Share

  478. TYDEMAN F, Craine N, Kavanagh K, Adams H, et al
    Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    J Antimicrob Chemother. 2021;76:2437-2445.
    >> Share

  479. MUNTEAN MM, Muntean AA, Guerin F, Cattoir V, et al
    Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
    J Antimicrob Chemother. 2021;76:2294-2301.
    >> Share

  480. SIX A, Mosbahi K, Barge M, Kleanthous C, et al
    Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    J Antimicrob Chemother. 2021;76:2317-2324.
    >> Share

  481. LI R, Peng K, Xiao X, Wang Y, et al
    Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis.
    J Antimicrob Chemother. 2021;76:2481-2483.
    >> Share

  482. VADLAMUDI NK, Saatchi A, Patrick DM, Rose C, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada.
    J Antimicrob Chemother. 2021;76:2419-2427.
    >> Share

  483. MACVANE SH, Bhalodi AA, Dare RK, Rosenbaum ER, et al
    Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest BC Kit.
    J Antimicrob Chemother. 2021;76:2453-2463.
    >> Share

  484. COCCITTO SN, Fioriti S, Cinthi M, Morroni G, et al
    Detection of phenicol-oxazolidinone resistance gene optrA in Aerococcus viridans from bovine faeces, Italy.
    J Antimicrob Chemother. 2021;76:2479-2481.
    >> Share

    July 2021
  485. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016